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1. Introduction 
 
 
1.1 Homogeneous metal-promoted asymmetric catalysis 
 
The very first synthesis of chiral molecules by means of homogeneous 
metallic catalysts were reported in 1966 and 1968, by the groups of Nozaki 
et al. [1], Horner et al. [2] and Knowles and Sabacky [3]. The ee‘s were 
lower than 15%, but those experiments were the proof of principles: a metal 
complex with a chiral ligand is able to promote a catalytic reaction where 
non chiral or racemic substrates are converted into chiral products with 
preference for one enantiomer. Due to the increasing interest in this field, 
dramatic improvements were made in the next decades; the prime examples 
are the works of Noyori [4], Sharpless [5] and Knowles [6], who were 
awarded of the Nobel prize in 2001 "for their work on chirally catalysed 
hydrogenation reactions and on chirally catalysed oxidation reactions".   
Nowdays, enantiopure chiral molecules are required in several productions, 
such as pharmaceuticals and vitamins [7], agrochemicals [8] and flavors and 
fragrances [9]. Other applications are functional materials such as chiral 
polymers, materials with non-linear optical properties or ferroelectric liquid 
crystals [10]. For many applications of such chiral compounds, the racemic 
forms will no longer be accepted [7, 8]. On this basis, different general 
approaches have been developed for the production of enantiopure or 
enantioenriched chiral molecules:  
 
1) classical separation of enantiomers. This methodology is based on 
the resolution of diastereoisomeric adduct by crystallization or, on 
smaller scale, on the separation of enantiomers by chiral HPLC. In 
both cases, large amounts of solvents have to be handled and at least 
50% of the material with the wrong absolute configuration has to be 
either recycled or discarded. 
2) the use of building blocks from the chiral pool, is very often chosen 
in the early phases of drug development but, depending on the 
commercial availability of the starting material, it can also be used 
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for large-scale products. Because natural products very often have 
high enantiomeric purity, no further enrichment is usually necessary. 
3) enantioselective synthesis with chiral auxiliaries, which are not 
incorporated in the target molecule but are removed after the 
stereogenic centres have been established, is an alternative, but it 
should be considered that additional steps are required, and the 
chiral auxiliarie must be either recycled or discarded. 
4) enantioselective catalysis, where prochiral starting materials are 
transformed to enantioenriched products with the help of chiral 
catalysts. Effective catalysts are either synthetic (chemocatalysis, i.e.  
metal complexes or organocatalysts) or can be of natural origin 
(biocatalysis). 
 
Depending on the specific case study, one of those methods may be the best 
one but, as a general consideration, the enantioselective catalysis should be 
considered the more efficient in terms of atom economy [11] and the more 
responding the the principles of green chemistry [12] (―Green chemistry 
efficiently utilizes (preferably renewable) raw materials, eliminates waste 
and avoids the use of toxic and/or hazardous reagents and solvents in the 
manufacture and application of chemical products‖ [12b]). In particular, 
homogeneus metal-promoted asymmetric catalysis, compared with 
asymmetric biocatalysis, asymmetric heterogeneous catalysis or asymmetric 
organocatalysis, is attractive due to its versatility in terms of reaction 
conditions, reactivity and fine tuning of the catalyst [13]. Nevertheless, it is 
not a paradox that relatively few enantioselective catalysts are used on an 
industrial scale; asymmetric catalysis is a young discipline, and its 
application presents some special challenges and problems, such as: the 
small scale, the cost of the metal, the substrate specificity, the development 
time and the cost and availability of the  chiral ligand. 
In order to generalize the principles of homogeneus metal-promoted 
asymmetric catalysis, the role of three main components should be 
considered: the metal, the substrate and the ligand.  
Usually the metal activates the substrates in order to make them more 
reactive. The activation takes places in different ways depending on the 
selected system, and examples range from simple interaction as Lewis acid 
(Dies-Alder) to more complex interactions with delocalized orbitals of the 
substrate (π-allyl complexes in the Asymmetric Allylic Alkylation). 
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Alternatively, the metal can play the role of group-transfer (Mn promoted 
asymmetric epoxidations) or cross-coupler (Suzuki-Miyaura reaction). On 
this basis, it is evident that the proper chose of the metal is fundamental to 
obtain the right balance of the catalyst proprieties. 
The substrates involved in the homogeneus metal-promoted asymmetric 
catalysis are usually prochiral or racemic. In the first case, interaction of the 
two enantiofaces of the substrates with the chiral complex lead to 
diastereoisomeric reaction pathways, which implies kinetic preference for 
one enantiomer of the product. Similar considerations can be done for the 
interaction of the two enantiomers of racemic substrates, taking also into 
account that the two enantiomer may be in equilibrium (dynamic kinetic 
resolution) or not (kinetic resolution).  
The chiral ligand has a double function, tuning the electronic proprieties of  
the metal and directing the stereochemistry of reaction by sterical interaction 
with the substrate. 
As a matter of fact, the topic of this introductive paragraph is a ―mare 
magnum‖. Several asymmetric processes and a huge variety of chiral ligands 
exist, and this diversity reflects the scope of the modes of asymmetric 
induction. Among those, in 2002 a few selected ligands were indicated as 
‗privileged‘ by Jacobsen [14] (in brackets in Figure 1.1), in order to define 
structures of wide and proven applicability both in the development of new 
asymmetric processes, both in the improvement of existing ones. Over the 
years, this original class of privileged ligands was gradually extended to 
include other effective structures, and in 2008, the Aldrich Chemical 
Company reviewed an entire class comprising more than 30 structures (in 
Figure 1.1). 
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Figure 1.1 
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1.2 Carbohydrates as building blocks of “privileged” ligands. 
 
The accurate design of the chiral ligand is crucial for its effective 
application. The ligand must possess a well-defined three-dimensional 
structure, capable of directing the stereochemistry of the reaction. Several 
research groups demonstrated that highly performing ligands can be obtained 
by simple modification of molecules from the natural chiral pool, such as 
carbohydrates [16]. This strategy is based upon the following assumptions: 
 
 Sugar are abundant building blocks, therefore easily available. This 
feature is important since, as mentioned before, the cost of the ligand 
may limit its application in asymmetric processes. 
 Carbohydrates are intrinsically chiral, available in nature as 
enantiopure molecules and they present more centres of chirality. 
This allows to synthesize chiral ligands starting from natural sugars 
without any complicated resolution of racemates. 
  Several functional groups are present on the sugar backbone, 
usually hydroxy and amino groups. Those may easily and selectively 
be functionalized, using easy and assessed synthetic procedures. 
This allows a simple tuning of the chemical-physical proprieties of 
the ligand, such as selective solubility into a green solvent suitable 
for multiphase catalysis. Moreover, the high ability of being 
functionalized is particularly attractive because modular ligands with 
similar structural motifs can be created, thus making possible the 
generation of libraries. 
The use of sugar as building blocks for chiral ligands is expected to be 
especially productive when carbohydrates are used as backbone of 
―privileged‖ ligands, aiming to amplify the scope of their application. The 
introduction of privileged moieties into a sugar backbone promises to afford 
unique ligand structures, which combine efficiency with convenience and 
flexibility. The sugar versions of these well-known ligands are more 
versatile compared to the classic version, because  activity and selectivity are 
supposed to be the similar, due to the similar coordinating environment, but 
the sugar backbone allows an easier tuning of the chemical-physical 
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proprieties. This was demonstrated on several occasions, and today many 
―privileged‖ ligands of Figure 1.1 do possess a corresponding sugar version 
[16g].  
An additional benefit is that the generous presence of functional groups in 
sugars can be employed for ―tagging‖ the ―privileged‖ ligands in view of 
their application in multiphase homogeneous catalysis. This methodology 
allows easy catalyst re-cycling via simple phase separation, and relies on 
using two immiscible solvents and a phase-tagged catalyst, which is 
selectively soluble in one of the two solvents (catalyst phase), while being 
insoluble in the other solvent (reactant/product phase)[17]. 
Given this premise, the research group, where this PhD thesis was carried 
on, focalized the last years activity in the development of sugar-derived 
chiral ligands, which are analogues of the privileged ligands derived from 
trans-1,2-cyclohexanediamine (namely, Trost‘s ligand, DACH-Py ligand, 
and Salen ligand of Figure 1.1). This aim was accomplished by simple and 
immediate derivatisation of common carbohydrates, such as D-glucose [18]. 
Interest towards this class of molecules is due to the analogy between trans-
1,2-cyclohexanediamine and the 2,3 diaminoglucose, because in both cases 
the coordinating function are in the trans-diequatorial adjacent position of a 
six members ring. The general structure of these ligands was named Naple-
type, and is illustrated in Figure 1.2  
 
 
-X-L Asymmetric Catalytic applications 
-NHCH2Ar Cu promoted cyclopropanation 
-NH(CO)C6H4-2-PPh2  
Pd promoted Allylic Alkylation  
Cu promoted conjugate addition 
-N=CH-2-py  Mo promoted Allylic Alkylation  
-N=CHC6H4-2-OH Mn promoted epoxidation 
Figure 1.2 
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D-glucose is the sugar "building block", and its dress was optimized to 
ensure synthetic convenience and high performance in catalysis. More 
precisely, C-1 is glycosylated with a benzyl group, which can be selectively 
introduced in α-position. Positions 2 and 3 are decorated with the 
coordinating functions that typically characterize the privileged ligands 
based on chiral trans-1,2-diaminocyclohexane (DACH-salen, DACH-py and 
Trost ligands). Finally, the ―auxiliary‖ positions 4 and 6 are generally 
protected with a benzylidene ring, which stabilizes the chair conformation of 
the sugar ring. This option can be advantageous for the result of the 
catalysis. At the same time, the protection can be easily removed and 
replaced by more specific tags [18c, 19] . Over the years, the Naple-type 
library was successfully examined in several asymmetric reactions involving 
unsaturated substrates, in both traditional and unconventional conditions [18, 
19, 20]. 
However, in each of these enantioselective processes, only one enantiomer 
of the chiral product can actually be favored. In fact, for privileging the 
production of the other one, use of the enantiomeric ligands based on L-
glucose would be necessary. This alternative is unlikely due to the high cost 
of this non-natural sugar. At the same time, it should be considered that in 
some notable cases, both enantiomers of a molecule do present wanted 
properties, and, hence, it is necessary to find convenient methods for their 
synthesis. For instance, (+S,R,R,R)-nebivolol and (-R,S,S,S)-nebivolol 
synergistically act to produce a highly beneficial cardiovascular profile [21]. 
Within this thesis, it was explored the possibility to develop ligands pseudo-
enantiomeric to Naple-type and based on the same D-glucose scaffold. Aim 
of this strategy is the production of the same chiral products with opposite 
stereochemistry.  
 
 
1.3 Pseudo-enantiomeric ligands based on pyranose. Primary 
aim of the thesis: the elpaN-type library. 
 
From now on, we shall define as pseudo-enantiomeric those pyranoses 
derived ligands that possess the same connectivity within the cyclometallated 
ring, and, on the basis of a rational design, provide enantiomorphous 
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coordination environment. This definition is based on the assumption that  
the enantioselectivity of a reaction depends only on the local chirality in 
close proximity to the active metal center [22a]. On this basis, it is possible 
to direct the enantioselectivity of a system by a proper design of the active, 
chiral, catalytic center.  
This goal may be achieved in different ways on the case of sugar-derived 
ligands, taking in account some simple considerations. As mentioned before, 
most of the ligands based on trans-1,2-disubstitued-cyclohexane do present 
the coordinating functions L in adjacent trans-diequatorial position of the 
six-member ring. Figure 1.3 shows the two corresponding enantiomers (a e 
b).  
 
Figure 1.3 
These relative configurations can be easily obtained in several ways within 
the stable chair of the most convenient pyranoses.  
For instance, positioning the donor atoms in positions 2 and 3 of glucose (as 
in Naple-type) (Figure 1.4a) replies the relative configuration of Figure 
1.3a. Then, a simple shift of the coordination sites to positions 1β and 2 
clearly produces a pseudo-enantiomeric environment (Figure 1.4b). The 
same effect (Figure 1.4c) occurs involving positions 3 and 4 of mannose (or 
even of the same glucose). 
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Figure 1.4 
 
In other notable cases, the coordinating functions L are not directly bound to 
the six-member ring of cyclohexane, but are spaced with a linker X.  
Seen along the oriented C(XL)—C(XL) axis, in both enantiomers the C—
X(L) vectors give rise to a dihedral angle, the sign of which can be defined 
as positive, if the overlap of the upper L over the lower L requires a 
clockwise rotation (Figure 1.5a), negative in the other case (Figure 1.5b). 
 
Figure 1.5 
 
In most of the catalytic processes, the sign of the dihedral angle regulates the 
stereochemical outcome of catalysis. In other words, in any given reaction, 
ligands with the same sign of dihedral angle will favor the obtaining of the 
same enantiomer. These relative spatial arrangements can be obtained in 
several ways in the stable chair of the most convenient pyranoses, For 
instance, the positive sign ensues from an appropriate di-equatorial 
substitution (e.g. 2,3 in the glucose ring, Figure 1.6a), but also from an 
axial,equatorial arrangement (e.g. 3,4 in galactose, Figure 1.6a’). 
In analogous way, use of other suitable couples and/or sites affords the 
opposite dihedral angle, as the illustrated by the examples of Figure 1.6b 
and 1.6b’.  
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Figure 1.6 
  
Given this premise, it is clear how, depending on the circumstances, it is 
possible to find the most convenient synthetic strategy for designing modular 
libraries of pseudo-enantiomeric ligands, with a well-defined stereochemical 
activity; some exemples are reported in literature [22]. 
The main aim of this PhD thesis was concentrated on the development of a 
library of ligands, derived from D-glucose, pseudo-enantiomeric to the 
previously cited Naple-type library. This innovative library of ligands was 
called elpaN-type (Figure 1.7, the name elpaN come from the world Naple 
spelled on the contrary), and was successfully employed in the same relevant 
asymmetric processes promoted by the Naple-type library, but with opposite 
enantioselectivity. 
 
Figure 1.7 
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According to the strategy mentioned before, this aim was pursued by shifting 
the same coordinating motifs X-L, respectively from positions 2,3 (Naple-
type) to position 1,2 (elpaN-type). The multifunctional nature of the 
carbohydrate scaffold was also employed for a precise tailoring of the 
ligands, through the introduction of appropriate phase-tags in the other 
available ring positions. Depending on the type of functionalization X-L, 
three subsets of ligands were prepared.  
When X-L was a 2-diphenylphosphinoamido arms, typical motif of the 
privileged Trost‘s ligand, the library was named elpaN-phos and was 
employed in the Pd promoted asymmetric allylic substitution (Scheme 1.1). 
 
 
 
Scheme 1.1 
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When X-L was a amido-pyridin arm (DACH-Py like ligand), the ligands, 
named elpan-Py family, were used in the Asymmetric Allylic Alkylation 
(AAA) of allylic carbonate promoted by Mo and assisted by microwaves 
irradiation (MW) (Scheme 1.2). 
 
 
 
 
Scheme 1.2 
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At last, when the ligands were funtionalized by an iminohydroxyphenyl arm, 
like the DACH-Salen, they promoted the manganese-catalysed asymmetric 
epoxydation of styrene (Scheme 1.3). 
 
Scheme 1.3 
 
 
1.4 Secondary aim of the thesis: Pd (0) complexes with sugar-
derived ligands for aqueous Suzuki-Miyaura cross-coupling. 
As mentioned before, organometallic catalysis is a powerful tool for the 
reduction of pollution by the use of the green chemistry principles. In fact, 
metal catalysts are able to produce clean and high selective reactions, thus 
saving time and reducing separation steps and waste of auxiliaries. 
Furthermore, the high tunability of metal complexes allows accurate 
tailoring of their properties, for performing catalysis in non-toxic alternative 
solvents. This latter features is particularly attractive because the choice of 
the solvent strongly affects the impact of a reaction.  
An ideal solvent should be capable to dissolve reagents or products, 
chemically inert ( it must not react both with reagents and products), liquid 
at temperature and pressure demanded by the reaction, available in large 
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quantity, economically affordable, not toxic (towards humans, animals and 
environment) and not flammable [23]. These considerations allow to select 
four possible alternative solvents [24]:  water, ionic liquids, perfluorinated 
solvents, supercritical solvents. 
Among them, water is the only one solvent that instead of being toxic, is 
indispensable to life. Aqueous media were not generally used in synthetic 
processes for their poor ability to dissolve organic compounds and for the 
reactivity that many compounds show towards water. Nevertheless, this 
solvent displays several benefits: 
1) is not flammable; 
2) is polar and easily separates from apolar organic solvents; 
3) is amphoteric; 
4) is available in large quantities and economically affordable; 
5) is odorless and colorless, that makes easy to detect contaminations; 
6) dissolves many gases; 
7) its density is different from that of most organic solvents; 
8) can affect advantageously the kinetic of reactions. 
 
Organic processes promoted by metals in aqueous media are, therefore,  
currently of great interest, due to the green nature of water[25].  
On the ground of the previous considerations, secondary aim of the thesis 
has been the synthesis of hydrophilic complexes of Pd(0) containing 
diphenylphosphino,imino (PN) and pyridino,imino (NN) bidentate ligands 
derived from sugars (Figure 1.8), taking advantage of their solubility in 
water:  
 
Figure 1.8 
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The design of the ligands was aimed at ensuring their easy, high-yield 
synthesis. Four imino sugar residues were employed: three derive from 
glucose functionalized in positions C1, C2 and C6, respectively. The fourth 
is instead a mannoside derivatized at C6. 
As expected, all the complexes were found to be highly soluble in aqueous 
media, and could be fruitfully employed in the Suzuki-Miyaura coupling 
(Scheme 1.4).  
 
Scheme 1.4 
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2. The elpaNphos ligands: Pd promoted 
Asymmetric Allylic Substitution. 
 
 
2.1 Background of the Pd promoted Asymmetric Allylic Substitution: 
scope of the reaction, mechanisms, state of the art. 
 
The first stoichiometric, palladium-mediated, allylic substitution was 
reported by Tsuji in 1965 [1]. In this seminal work it was shown that soft 
carbon nucleophiles, such as ethyl malonate and acetoacetate, react with 
dimeric π-allyl palladium chloride to afford allylated products. In 1970, 
Atkin et al. and Hata et al. published papers about  a catalytic version of the 
reaction [2, 3], and in 1977 Trost reported the first palladium-catalyzed 
asymmetric allylic alkylation [4].  
In the next decades, the Tsuji–Trost reaction has known a remarkable 
development and numerous transition metals such as molybdenum [5], 
tungsten [6], iridium [7], rhodium [8], ruthenium [9], platinum [10], nickel 
[11], copper [12], iron, and cobalt [13] have been recognized as efficient 
catalysts for this reaction. Nowadays, metal-promoted allylic substitution is a 
powerful tool for organic synthesis. Moreover, asymmetric allylic alkylation 
(AAA) has become a benchmark reaction to test the efficiency of new chiral 
ligands [14] and has been widely used as a key step for the preparation of 
bioactive compounds [15]. 
The generic Pd-promoted  asymmetric allylic substitution is reported below 
(Scheme 2.1). 
  
 
Scheme 2.1 
 
The neat reaction is a substitution of a leaving group X, in allylic position, 
by a nucleophile. This occurs in milder condition than the tipical ordinary 
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SN2 or SN2‘ reactions and with different chemo-, regio- and 
stereoselectivities. The scope of the reaction is really wide in terms of 
nucleophile, substrate, and leaving group: 
 Nucleophiles: The most common nucleophiles, which lead to a 
formation of a new C-C bond, are soft (pKa below 20 [16]) 
carbanions stabilized by π-acceptors. In particular,  dimethyl 
malonate has become the standard nucleophile for testing new 
catalysts, but carbanions bearing carbonyl, sulfone, nitrile, or nitro 
groups have been used [17]. Only few exemples of hard C-
nucleophiles are reported [17]. By the way, heteroatomic (H, O, N, 
S, P) anions have been widely employed [15, 17]; specifically, due 
to the important role of chiral amine as pharmaceutical, N-
nucleophile are of great interest. Also, the use of chiral nucleophile 
is reported [18]. 
 Substrates: One of the reason for the success of the Pd-promoted 
asymmetric allylic substitution is that it is quite tolerant towards 
several functional group [15], allowing the wide use of this 
methodology in total synthesis of natural products. Hence, several 
substrate have been used. In terms of general structure, achiral, meso 
or racemic substrate can be converted to an optically active product 
by allylic substitution [15d]. The 1 and 3 positions of the allylic 
moiety may be symmetrically or unsimmetrically substituted, and 
also cyclic substrates are used; these structural feature will strongly 
influence the regio- and stereo- chemical outcome of the reaction 
(see mechanism, section 2.1.1) . Substrates with the proper requisites 
in terms of structure and functional groups undergo intramulecolar 
reaction. 
 Leaving groups: In the metal-catalyzed allylic substitutions rather 
unreactive leaving groups can be used which are usually inert 
toward nucleophiles in the absence of a catalyst [19]. The most 
typical substrates are allylic acetates and carbonates. Carbonates 
generates  alkoxide in the ionization step, and it  can serve as a base 
for generating the nucleophile Nu
–
 from the precursor Nu-H, 
avoiding the use of an external base [20]; the resulting steady low 
concentration of base allow the use of base-sensitive compounds. 
Allylic halides are not common substrate because imply the 
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drawback of the background uncatalyzed reaction, but some 
example are reported [21]. In cases where more reactive leaving 
groups are needed, phosphates may be a good choice [22]. 
Hundreds of chiral ligands have proven to efficiently promote this reaction, 
with a variety of backbones, coordinating motives and donating systems (P, 
P–P, P–N, P–O, P–S, N–N, N–S, S–S, and NHC) [23], but Trost‘s ligands 
are undoubtedly the most successful in asymmetric allylic substitutions 
(Figure 2.1) and, in a wide range of case-studies, they represent the state of 
the art in terms of catalytic performances and applicability.  
 
Figure 2.1  
 
Notable examples are the total synthesis of horsfiline, a natural product leaf 
extract with structural similarities to the active indole alkaloid natural 
products, the current synthesis of the (R)-vigabatrin, an important marketed 
drug for the treatment of epilepsy, and the syntheses of calanolide (-)-
calanolide A (R1 = H; R2 = OH) and (-)-calanolide B (R1 = OH; R2 = H), both 
natural products that demonstrate HIV-1 specific reverse transcriptase 
inhibition (Scheme 2.2).[24] 
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Scheme 2.2 
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2.1.1 Mechanism and enantiodiscrimination 
 
The mechanism of these reactions has been firmly established and a detailed 
picture of the catalytic cycle can be described [17, 19, 25]. The generally 
accepted mechanism of palladium-catalyzed allylic substitutions is shown in 
Scheme 2.3. 
 
 
Scheme 2.3 
 
An allylic substrate C1 reacts with the catalyst, which enters the catalytic 
cycle as Pd(0). Both Pd(0) and Pd(II) complexes can be used as precatalysts 
(typically [Pd(dba)2], [Pd(C3H5)Cl]2, PdCl2 and Pd(OAc)2), because Pd(II) is 
easily reduced in situ to the active Pd(0) form. Presumably, the reaction is 
initiated by formation of a π-complex which eliminates X– to produce an (η3-
allyl)palladium(II) complex. This process occurs with inversion of 
configuration. Depending on the ligand, the solvent and X
-
, the product of 
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the oxidative addition can be a cationic complex C2  or a neutral complex if 
the resulting anion X
–
 coordinates with palladium; classically, the more 
reactive cationic complex predominates when bidentate ligands are involved. 
The allyl complexes C2 can isomerize in various ways and this strongly 
influences the outcome of the reaction. It is worth to underline that the 
intermediate allyl complexes are stable and can be isolated in the absence of 
nucleophiles. This uncommon feature allowed valuable insights into the 
mechanism of allylic substitutions and the origin of enantioselection in 
reactions with chiral catalysts. The electrophilic Pd(II) center activates the 
allyl system for nucleophilic attack at the allyl termini, which usually is the 
rate limiting step. Addition of the nucleophile at C1 or C3 generates an 
unstable Pd(0)-olefin complex C3, which readily releases the final product 
C4 and enters again into the catalytic cycle. For soft nucleophiles, also the 
nucleophilic attack take place with inversion of configuration, because the 
nucleophile reacts with the allyl from the side opposite to palladium; as a 
consequence, the overall process proceeds with neat retention of 
configuration. On the contrary, hard nucleophiles such as organozinc 
reagents first coordinate to the metal center and then are transferred 
intramolecularly to the allyl; therefore, in this case the reaction occur with 
neat inversion of configuration.  
As mentioned before, allyl complexes show dynamic behaviour trough 
different processes, namely the π-σ-π isomerisation, the apparent allyl 
rotation and the Pd
0
-catalyzed alkyl exchange. These equilibriums should be 
taken in account in order to predict the stereo and regiochemical outcome of 
reaction. 
The  π-σ-π isomerisation (Scheme 2.4) is a syn-anti interconversion by 
rotation around the σ-(C-C) bond in the η1 -intermediate1.  
 
 
Scheme 2.4 
 
                                                          
1
 syn and anti refer to the positions syn and anti to the substituent at C2. 
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Usually the syn position is sterically favored and, consequently, more stable.  
An other isomerization processes that can occur by a π-σ-π mechanism is 
apparent allyl rotation, where the two termini of the allyl system switch 
position with respect to the other two coordination sites and at the same 
time, the central allyl C atom moves from one side of the coordination plane 
to the other. (Scheme 2.5).    
 
 
Scheme 2.5 
 
When A and B are different and chiral, as in chiral bidentate ligands, the two 
isomer C5 and C6 are diastereoisomers, then they can undergo nucleophilic 
addition with different rates and different regioselectivities and, 
consequently, the relative rate of apparent allyl rotation can strongly 
influence the product distribution of allylic substitutions, including the ee%. 
Catalytic amounts of anions such as chloride or fluoride [26] or polar 
solvents like DMSO and acetonitrile [27] that can coordinate to palladium 
have been shown to accelerate this process. Stabilization of the η1-
intermediates by coordination of an external ligand could explain these 
observations.  
In the Pd
0
-catalyzed alkyl exchange a Pd(0) complex adds to the free π- face 
of the allyl ligand and displaces the Pd(II), resulting in an inversion of 
configuration at all three allyl carbons (Scheme 2.6). Due to the low 
concentration of palladium (0), isomerization by allyl exchange is usually 
slow compared to product formation. 
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Scheme 2.6 
 
The origin of enantioselectivity is strongly dependent on the relative rate of 
these processes and the nucleophilic substitution, but also the symmetry of 
the ligand and the substrate play a foundamental role. Five different 
mechanisms of enantiodiscrimination may be observed [18 and reference 
cited therein]. 
The type A mechanism is quite common in asymmetric catalysis, and consist 
of the differentiation of the enantiotopic faces of a π-unsatured system 
(Scheme 2.7). The steric motif of the chiral ligand may induce preference 
toward the coordination of one enantioface of the substrate; for this reason, 
one of the two diastereoisomeric π-allyl complexes will be prevalent, and it 
will lead to the main enantiomer. On the basis of this mechanism, it is clear 
that the enantiodiscriminating step is the oxidative addition of the substrate 
to the metal; evidences are that 1) in intramolecular reaction racemic 
substrates leads to racemic products, and 2) enhancing the rate for the 
equilibration of the π-allyl intermediate lowers the ee%. 
 
 
Scheme 2.7 
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The type B mechanism differentiate between enantiotopic leaving group; 
also in this case the enantiodiscriminating step is the metal induced 
ionization of the leaving group. (Scheme 2.8) 
 
 
Scheme 2.8 
 
The stereochemical outcome of the reaction can clearly be explained on the 
basis of the cartoon model proposed by Trost for this reaction [28]. For 
Trost‘s-like ligands, the phenyl groups arrange as depicted in figure 2.2, 
altering ―flap‖ and ―wall‖ groups; the resulting system may be easily 
described by the quadrants formalism. The rate-limiting step is the activation 
of one leaving group in a to give a π-allyl intermediate (b or c). Activation 
of the ―left‖ leaving group function leads to the attainment of b, while 
activation of the ―right‖ function preludes the achievement of c. Both 
reactions occur with simultaneous rotation of the five-membered ring, which 
is clearly inhibited by steric contacts only in the case of the clockwise 
rotation (i) that accompanies formation of c. 
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Figure 2.2 
 
The type C mechanism involves a chiral racemic substrate which lose 
chirality when it is ionized into the  π - allylmetal intermediate. The two 
allylic termini are enantiotopic, and by differentiating between them it is 
possible to induce enantioselectivity; hence, the nucleophilic attack is the 
enantiodiscriminating step for this mechanism (Scheme 2.9). One possible 
way to differentiate between the two allylic termini is the use of bidentate 
heteroleptic ligands, such as P-S or P-N; due to the trans effect, the 
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electrophilic position trans to the P atom will be more reactive, and then 
preferred. Since this intermediate derives from a precursor in which the 
chirality of the substrate is lost, this deracemization constitutes a dynamic 
kinetic asymmetric transformation (DYKAT).  
 
 
Scheme 2.9 
 
An other exemple of DYKAT (when chiral substrates are used) where the 
nucleophilic attack is the enantiodiscriminating step is the type D 
mechanism; this is similar to type A, but in this case the π–allyl-metal 
intermediates interconvert faster than they are attacked by a nucleophile and 
asymmetric induction derives from differential rates of reaction of the two 
diastereomeric intermediates (Scheme 2.10). 
 
 
 
Scheme 2.10 
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Type E Mechanism involves discriminating between the enantiotopic faces 
of the nucleophile . (Scheme 2.11) 
 
Scheme 2.11 
 
 
2.1.2 State of the art: the Naplephos ligands. 
Within previous studies, the research group where this PhD thesis has been 
developed, contributed to the field of Pd-promoted asymmetric allylic 
substitution introducing the library of ligands Naple-phos, [29]  based on D-
glucose (Figure 2.3). The multifunctional nature of the carbohydrate 
scaffold is fully employed for a precise tailoring of the ligands: position 2 
and 3 display a  diphenylphosphinoamide  or diphenylphosphinoester arm, 
essential coordination motif of Trost‘s privileged ligands based on trans-
cyclohexanediamine. Positions 4 and 6 are instead useful for phase-tagging 
the ligands. Accordingly, the ligands were tested in traditional conditions in 
the Pd-catalysed desymmetrization of meso-cyclopent-2-ene-1,4-diol S1 
reported in Figure 2.3, a benchmarck reaction for these systems, affording 
the chiral products in high ees.  
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Figure 2.3 
 
This family of  ligand was also ―tagged‖ for performing the reaction under 
alternative conditions [29 b,c,e]. Thus, the polar versions depicted in Figure 
2.4 were prepared and used for the same reaction in the ionic liquid 
BMIMBF4, aiming to facilitate both separation and re-cycle of the catalyst. 
 
Figure 2.4 
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Naple-phos-3 and Naple-phos-4 essentially differ for the conformational 
rigidity imposed by the functionalization in positions 4 and 6, but both 
ligands were only moderately selective, and the (R,S)-product was obtained 
in 57% ee irrespective of their rigidity. Another result [29c] within the field 
of multi-phase catalysis was achieved by anchoring Naple-phos-3 to a 
commercial Stratosphere-CHO resin through ring positions not involved in 
coordination, i.e. C4 and C6 (Figure 2.5).  
 
Figure 2.5 
The supported ligand was reacted with a Pd precursor, and the resulting 
catalyst was examined in the desymmetrization of S1 according to the 
scheme of Figure 2.3. After each run, the solid was filtered and re-used. 
Gradual decrease in both activity and selectivity was recorded upon re-
cycling.   
 
 
2.2 The elpaN-phos ligands: synthesis and characterization. 
In order to validate the strategy of pseudo-enantiomeric ligands (see chapter 
1), the elpaN-phos library was rationally designed, presenting a specular 
stereochemistry of coordination related to the Naple-phos. According to the 
strategy mentioned before, within this study pseudo-enantiomeric ligands 
have been designed and prepared, aiming to produce the same Pd-promoted 
asymmetric allylic substitution with opposite stereochemistry. 
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Based on the relative orientations of positions 2 and 3 in naplephos ligands, 
this approach has been pursued by introducing the same essential 
coordinating motifs in positions 1 and 2, which clearly provide a pseudo-
enantiomeric coordination environment. It should be noted that Naple-phos-
1 and elpaN-phos-1 are ―truly‖ pseudo-enantiomeric according to the given 
definition, whereas in Naple-phos-2 the original amido linkage in 3 is 
replaced by an ester. This substitution is important because it greatly 
simplifies the synthesis of the ligand, without affecting its stereochemical 
properties. 
The very simple synthesis of the ligands elpaN-phos-1 and elpaN-phos-2 is 
reported in Scheme 2.12. This involved a new procedure for the ready 
attainment of the known key-intermediate 3,4,6-tri-O-acetyl-1,2-β-
glucodiamine 3. The precursor was the cheap glucosmine hydrochloride, 
which was treated with acetyl bromide to acetylate the hydroxyl groups, and 
to functionalize the C1 with a bromide selectively in α position, obtaining 1. 
In the second step, an azide group was substituted to the bromide by an Sn2 
mechanism, thus obtaining selectively the β anomer 2. In this way the 
nitrogen group was in the equatorial position. The reaction was performed 
using the azidotrimethylsilane as a source of azide and potassium tert-
butoxide as base and nucleophile that makes the azide available. In the next 
step, the azide was reduced to amine 3 by a typical Pd promoted 
hydrogenation. All the steps were almost quantitative and the products were 
purified by precipitation. Condensation of 3 with two equivalents of 
diphenylphosphinobenzoic acid (DPPBA) afforded elpaN-phos-1, which 
was highly soluble in common organic solvents, such as dichloromethane, 
THF and methanol. Treatment of the ligand with methanolic ammonia 
completely deprotected the acetyl groups, and the corresponding polar form 
of the ligand (elpaN-phos-2) could be obtained. This latter molecule is 
soluble in alcohols and in the most common ionic liquids, a feature 
particularly attractive as it allows performing biphasic asymmetric catalysis 
(see below).  
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Scheme 2.12 
 
The two ligands were fully characterized by 
1
H, 
13
C and 
31
P NMR 
spectroscopy, in order to confirm their structure and purity. The spectra are 
shown below. 
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1
H NMR spectrum of elpan-phos-1, 400 MHz, CDCl3 
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13
C NMR spectrum of elpan-phos-1, 100 MHz, CDCl3 
 
31
P NMR spectrum of elpan-phos-1, 162 MHz, CDCl3
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1
H NMR spectrum of elpan-phos-1, 400 MHz, CDCl3 
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13
C NMR spectrum of elpan-phos-1, 100 MHz, CDCl3 
 
31
P NMR spectrum of elpan-phos-1, 162 MHz, CDCl3 
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2.3 Catalytic performances of the elpaN-phos ligands in the Pd 
promoted Asymmetric Allylic Substitution. 
2.3.1 Intramolecular reaction 
Both elpaN-phos ligands represent the specular counterpart of naplephos 
family and, therefore, they were examined in the previously mentioned 
asymmetric desymmetrization of S1 for useful comparison. This 
intramolecular allylic substitution affords the key precursors of 
mannostatines, and is also a standard test for the assessment of the stereo-
orienting properties of new ligands [31].
 
Within this preliminary 
investigation, influence of temperature and additives on the catalysts 
performance was assessed (Table 2.1).  
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N° ligand T 
(K) 
solvent time conversion
b
 ee(%)
c
 
+(S,R)-P1 
1 elpaN-phos-1 298 THF
d
 5‘ >99% 95  
2 elpaN-phos-1 273 THF
d
 15‘ >99% 95  
3 elpaN-phos-1 258 THF
d
 30‘ 92% 96  
4 elpaN-phos-1 298 THF 30‘ >99% 84 
5 elpaN-phos-1 273 THF 30‘ >99% 86 
6 elpaN-phos-1 258 THF 30‘ >99% 86 
7 elpaN-phos-2 298 THF
d
 5‘ >99% 96 
8 elpaN-phos-2 298 bmpyBF4
e
 30‘ >99% 94 
9 elpaN-phos-2 298 bmpyBF4
e 
I recycle 
30‘ >99% 89 
10 elpaN-phos-2 298 bmpyBF4
e 
II recycle 
30‘ >99% 79 
11 elpaN-phos-2 298 bmimBF4
e
 30‘ >99% 90 
12 elpaN-phos-2 298 bmimBF4
e 
I recycle 
30‘ >99% 81 
13 elpaN-phos-2 298 bmimBF4
e 
II recycle 
30‘ >99% 77 
aCatalyst:substrate 1:20. bDetermined by NMR spectra of the crude reaction mixtures. 
cDetermined by HPLC on Chiracel OD-H, using 2-propanol/hexane 1:10, 1.0 mL/min, UV 
(254 nm), (–)-(R,S)-P1: 22–24 min; (+)-(S,R)-P1: 30–32 min. d Triethylamine as additive. 
eCatalyst:substrate 1:10. Triethylamine as additive.  
 
Table 2.1 
The following should be observed: 
(i) as desired, elpaN-phos ligands produced preferential formation of the 
opposite enantiomer with respect to Naple-phos ligands, +(S,R)-P1 vs -(R,S)-
P1. 
(ii) in THF (entries 1-7), the reaction proceeded in high yield within short 
reaction times.  
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 (iii) the marked beneficial influence of an added base was demonstrated 
[31e]: the ee of the reaction increased in the presence of triethylamine (entry 
1 vs 4 or 2 vs 5 or 3 vs 6). 
(iv) lowering the temperature from 298 to 258 K poorly influenced the 
enantioselectivity, with a little favorable effect. Thus, the optimal reaction 
conditions were found at 298 K in the presence of triethylamine, which 
allowed the attainment of the product within only 5’ in 95-96% ee with both 
ligands (entries 1 and 7). This also demonstrates that the presence of diverse 
phase-tags has no effects on the stereochemistry of the reaction.  
The stereochemical outcome of the reaction can be clearly explained on the 
basis of the mechanism proposed by Trost for this reaction.[31a] In our case, 
his cartoon models can be translated as in Scheme 2.13, where, of the sugar 
moiety, only the chair has been reported for sake of clarity. The rate limiting 
step is the activation of one carbammate in I to give a π-allyl intermediate 
(II or II’). Activation of the ―left‖ carbammate function (step i) leads to the 
attainment of II, which then results in -(R,S)-P1, while activation of the 
―right‖ function (step ii) preludes to the achievement of +(S,R)-P1. Both 
reactions occur with simultaneous rotation of the five-member ring, which is 
clearly inhibited by steric contacts only in the case of the clockwise rotation 
(i) which accompanies formation of II. 
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Scheme 2.13 
(v) finally, according to our assumption, the presence of free hydroxyls in 
enpalphos-a’ allowed the catalytic study in ionic liquids,2 where the original 
Trost ligand based on trans-cyclohexanediamine does not show appreciable 
solubility.  
                                                          
2
 Two convenient ionic liquids were used: 1-butyl-3-methylimidazolium 
tetrafluoroborate (bmimBF4) and 1-butyl-4-methylpyridinium tetrafluoroborate 
(bmpyBF4). 
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The reactions were performed by adding the substrate and triethylamine to a 
solution of the catalyst at 298 K. After 30 minutes the organic product was 
extracted with diethyl ether and analyzed. The catalyst phase was re-cycled 
for further runs. In bmpyBF4, the first run quantitatively afforded the chiral 
product in high ee (94%, entry 8), which is the highest value reported so far 
[29a,c] for this reaction under unconventional conditions. In the subsequent 
recycles the conversion was still high (entries 9 and 10), and, as rarely 
observed in ionic solvents for AAA,[32] the enantioselectivity only slightly 
decreased. After the second re-cycle, the catalytic solution was left aside, 
and 24 hours later, fresh substrate was added to the resting catalyst. Notably, 
the product was again obtained in quantitative yield and with significant ee 
(55%).  
Similar general behavior was observed in bmimBF4, where the ee were 
comprised within 90 and 77% ee. 
 
 
2.3.2 Intermolecular reaction 
The pseudoenantiomeric ligands elpaN-phos-1 and Naple-phos-2 were also 
tested in the desymmetrization of cis-4-ciclopenten-1,3-dibenzoate S2, using 
different nucleophile in order to explore the scope of these ligands in the C-
C, C-N and C-O bond formation (Scheme 2.14).  
 
Scheme 2.14 
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A preliminary screening was performed, in order to set up the reaction 
conditions, using Naple-phos-2 as ligand and dimethylmalonate as 
nucleophile. (Table 2.2). Both decreasing the temperature to 0°C and the 
nucleophile/substrate ratio strongly increased ee and influenced selectivity. 
Moreover, the only difference of energy between diastereoisomeric 
pathways of reaction cannot explain such a difference of enantioselectivity 
for the two different temperatures [33]; this behaviour was clarified by Trost 
[17], assuming that the minor enantiomer obtained in the first nucleophilic 
attack react faster in a second attack, because the favoured leaving group is 
available for ionization (Scheme 2.15). This enhances the ee for the main 
enantiomer but decreases the yield for increasing reaction times. Moreover, 
this phenomenon explains the better selectivity and the lower ee for a higher 
substrate/nucleophile ratio (entry 2 vs 3).    
N° 
Substrate/ 
Nucleofile 
T 
(K) 
Time 
(min) 
Conversion
a
 
(%) 
Selectivity
b
 
(%) 
Yield  
(%) 
ee 
(1R,4S) 
(%)
c
 
1 1/2.8 298 10 >99 11 11 87 
2 1/2.8 273 10 >99 40 40 >99 
3 1/1 273 40 67 >99 67 90 
Reaction conditions:  THF dry, 0.27 mmol of substrate, 0.27 or 0.75 mmol of 
dimethylmalonate, 0.75 mmol of  NaH, 0.0054 mmol of [Pd(Cl)(η3-C3H5)]2, 0.016 mmol of 
Naple-phos-2. a Determined by 1HNMR spectroscopy on the crude of reaction b Expressed as 
percent of monosubstituted product over the total mono- and disubstituted product;  
determined by 1HNMR spectroscopy on the crude of reaction c Determined by HPLC on 
Chiracel OD-H, using 2-propanol/hexane 1:99, 1.0 mL/min, UV (254 nm), rt: (1R,4S) 15.6 
min, (1S,4R) 17.2 min.  
Table 2.2 
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Scheme 2.14 
The rection conditions which maximized the yield, in particular the ratio 
substrate/nucleophile = 1/1, were used for the screening of nucleophiles with 
the two pseudoenantiomeric ligands (Table 2.3). As expected, Naple-phos-2 
and elpaN-phos-1 induced opposite enantioselectivity, but in all cases the 
latter one resulted in better selectivity for all the nucleophiles.  
(i) Satisfactory results were achieved with dimethylmalonate (entry 1 and 2), 
but a drop of yield was observed for the Naple ligand. 
 
(ii) The two ligands shown similar performances with N-
benzylmethylamine, as expected on the basis of the literature (entry 3 and 4). 
[35] 
 
(iii) The performances of the ligands were unsatisfactory for the phenol 
(entry 5 and 6), probably because the the Pd
0
-catalyzed alkyl exchange is 
competitive with the slow nucleophilic attack, and this allow epimerization 
of the allyl complex. 
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N° Ligand Nucleophile 
T 
(K) 
t 
(h) 
Conv.
a 
(%) 
Seletivity
b
 
(%) 
ee%
 c
 
1
d
 
Naple-
phos-2 
CH2(CO2Me)2 273 0.67 67 >99 
90 
(1R,4S)
e
 
2
d
 
elpaN-
phos-1 
CH2(CO2Me)2 273 0.67 25 >99 
71 
(1S,4R)
e
 
3
f
 
Naple-
phos-2 
NH(Me)CH2Ph 273 2.5 80 >99 74(-)
g
 
4
f
 
elpaN-
phos-1 
NH(Me)CH2Ph 273 2.5 84 >99 72(+)
g
 
5
h
 
Naple-
phos-2 
PhOH 303 16 56 >99 
36(-)-
(1S,4R)
i
 
6
h
 
elpaN-
phos-1 
PhOH 303 16 50 >99 0 
 a Determined by 1HNMR spectroscopy on the crude of reaction b Expressed as percent of 
monosubstituted product over the total mono- and disubstituted product;  determined by 
1HNMR spectroscopy on the crude of reaction. c Determined by HPLC on Chiracel OD-H, 
using 2-propanol/hexane 1:99, 1.0 mL/min, UV 254 nm. d Reaction conditions:  THF dry, 
0.27 mmol of substrate, 0.27 of nucleophile, 0.27 mmol of  NaH, 0.0054 mmol of [Pd(Cl)(η3-
C3H5)]2, 0.016 mmol of Ligand. 
e rt: (1R,4S) 15.6 min, (1S,4R) 17.2 min.  f Reaction 
conditions:  THF dry, 0.27 mmol of substrate, 0.27 of nucleophile, 0.27 mmol of  NEt3, 
0.0054 mmol of [Pd(Cl)(η3-C3H5)]2, 0.016 mmol of Ligand. 
g rt: (-) 9.73 min, (+) 13.2 min- h 
Reaction conditions:  THF dry, 0.27 mmol of substrate, 0.27 of nucleophile, 0.27 mmol of  
NaH, 0.0054 mmol of [Pd2(dba)3CHCl3], 0.016 mmol of Ligand. 
i rt: (+)-(1R,4S) 10.7 min, (-
)-(1S,4R) 18.4 min. absolute configuration assigned on the basis of the literature [34]. 
Table 2.3 
 
2.4 Conclusion. 
In conclusion, this work substantiates the strategy aimed at preparing 
effective ligands in a simple way from the chiral pool. Thus, the elpanphos 
library was designed by starting from convenient glucosamine 
hydrochloride, proving to be much more viable compared to species 
otherwise accessible only from the expensive L series.  
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Furthermore, the natural presence of polar phase-tags in the multifunctional 
[36] sugar structure allowed to perform the same asymmetric process in 
ionic liquids and with unprecedented enantioselectivity.  
 
2.5 Experimentals. 
2.5.1 General Considerations:  
 
NMR spectra were recorded in CDCl3 (CHCl3, δ = 7.26 ppm, and 
13
CDCl3 δ 
= 77 ppm, as internal standards) with a 200 MHz (Varian Model Gemini) 
and a 400 MHz (Bruker DRX-400). 
31
P NMR experiments were carried out 
by using aqueous 85% phosphoric acid as external reference (δ = 0 ppm). 
Specific optical rotatory powers [α] were measured with a Perkin–Elmer 
Polarimeter (model 141) at 298 K and 589 nm in chloroform or in methanol 
(c = 1.0 g/100 mL). THF was distilled from LiAlH4, dichloromethane from 
CaH2, diethyl ether from Na. 
 
 
2.5.2 Preparation of 3,4,6-Tri-O-acetyl-β-1,2-D-diamineglucose (3):  
 
 
 
a solution of 1-bromo-3,4,6-tri-O-acetyl-α- d-glucosamine hydrobromide (1) 
(2.0 g, 4.5 mmol) in THF (50 mL) was treated with TMSN3 (0.59 mL,  4.5 
mmol) and tBuOK (2.1 eq, 1.1 g, 9.5 mmol). After stirring for 18 h, KBr was 
filtrated and the solvent was removed under vacuum. The residue was 
dissolved in DCM (2.0 mL) and  filtrated over celite. Hexane was added to 
precipitate 1-azido-3,4,6- tri-O-acetyl-β-d-glucosamine (2) as a yellow solid 
in quantitative yield. The compound was dissolved in ethyl acetate (10 mL) 
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in the presence of 10% Pd/C (0.18 g) and treated with H2 (1 atm) for 1.5 h. 
After filtration, the solvent was removed under vacuum to afford pure 3,4,6-
tri-Oacetyl-β-1,2-D-diamineglucose (3) in quantitative yield. 
 
 
2.5.3 Preparation of elpan-phos-1:  
 
 
 
A solution of 3,4,6-tri-O-acetyl-β-1,2-D-diamineglucose (3) (0.61 g, 2.0 
mmol), diphenylphosphanylbenzoic acid (1.2 g, 2.0 mmol), 4-
dimethylaminopyridine (0.49 g, 4.0 mmol) and 1,3-
dicyclohexylcarbodiimide (0.82 g, 4.0 mmol) in dry dichloromethane (10 
mL) was stirred for 18 h at room temperature under inert atmosphere to 
afford a suspension. The residue was removed by filtration. The resulting 
solution was evaporated under vacuum, and the residue was 
chromatographed on silica gel (2:1 ethyl acetate: hexane) to afford the pure 
product as a white solid (1.2 g, 72%). C50H46N2O9P2 (880.87): calcd. C 
68.18, H 5.26, N 3.18; found C68.72, H 5.34, N 3.35. [α] = 3.5 (c 1.0, 
CHCl3). 
1
H NMR: δH = 7.85 (m, 1 H), 7.58 (d, 
3
JNH-H1=9.0Hz, 1 H, NH), 7.47 
(m, 1 H), 7.36-6.97(m, 26 H), 6.37 (d,
 3
JNH-H2=8.5Hz, 1H, NH), 5.29 (t,
 3
JH1-
NH=
3
JH1-H2, 1H, 1-H), 5.18(t, 
3
JH4-H3=
3
JH4-H5=9.5 Hz; 1 H, 4-H), 5.02 (t, 
3
JH2-
H3=
3
JH3-H4, 1H, 3-H), 4.47 (q, 1H, 2-H), 4.17 (dd, 
3
JH6-H5=4.11 Hz, 
2
JH6-
H6‘=12.4 Hz, 1H, 6-H), 3.94 (dd, 
3
JH6‘-H5=1.86, 1H, 6‘-H), 3.63 (m, 1H, 5-H), 
1.99 (s, 3H, AcO), 1.96 (s, 3H, AcO), 1.93 (s, 3H, AcO)ppm. 
13
C NMR: δc 
=172.3, 171.2, 170.8, 169.7, 168.8, 141-127 (aromatici), 80.8, 73.8, 73.3, 
68.14, 62.2, 53.9, 21.4, 21.2, 21.0 ppm. 
31
P NMR: δP= -8.0, -12.0 ppm. 
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2.5.4 Preparation of elpan-phos-2: 
 
 
 
Preparation of Elpanphos-a_: A solution of elpanphos-a (0.44 g, 0.50 mmol) 
in methanol (5 mL) was saturated with gaseous ammonia. After a few hours, 
addition of diethyl ether (50 mL) caused 
precipitation of the product as a white solid, which was filtered, washed with 
diethyl ether and dried under vacuum (0.30 g, 80%). C44H40N2O6P2 
(754.76): calcd. C 70.02, H 5.34, N 3.71; found C 
69.77, H 5.41, N 3.59. [α] = 10.5 (c 1.0, MeOH). 1H NMR: δH = 7.85 (m, 1 
H), 7.70 (m, 1 H), 7.5-6.9(m, 26 H), 5.09 (d,
 3
JH1-H2=9.7Hz, 1H, 1-H), 4.05 (t,
 
3
JH3-H2=9.9Hz, 1H, 2-H), 3.87(d, 
2
Jgem=12.5 Hz, 1 H, 6-H), 3.71 (dd, 
3
JH6‘-
H5=4.9Hz, 1H, 6‘-H), 3.65-3.30 (m, 3H, 3-H, 4-H, 5-H)ppm. 
13
C NMR: δc = 
174.6, 172.6, 145-130 (aromatici), 82.8, 81.0, 77.6, 73.2, 64.1, 58.0 ppm. 
31
P 
NMR: δP = -7.0, -10.5 ppm. 
 
 
2.5.5 Desymmetrization of meso-2-Cyclopenten-1,4-diol-isocyanate 
(S1) in THF:  
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Without NEt3: meso-2-cyclopenten-1,4-diol-isocyanate (S1) (0.10 g, 0.20 
mmol), [Pd2(dba)3]·CHCl3 (0.005 g, 0.005 mmol) and the ligand (0.015 
mmol) were dissolved in dry THF (1 mL). The mixture was stirred at the 
desired temperature, and, after the required reaction time, the solvent was 
removed under vacuum. Column chromatography on silica gel (1:2 ethyl 
acetate/hexane) gave the desired product as a white solid in 80–85% yield.  
 
With NEt3: meso-2-cyclopenten-1,4-diol-isocyanate (S1) (0.10 g, 0.20 
mmol), [Pd2(dba)3]·CHCl3 (0.005 g, 0.005 mmol) and the ligand (0.015 
mmol) were dissolved in dry THF (1 mL) containing triethylamine (0.030 g, 
0.30 mmol). The mixture was stirred at the desired temperature, and, after 
the required reaction time, the solvent was removed under vacuum. Column 
chromatography on silica gel (1:2 ethyl acetate/hexane) gave the desired 
product as a white solid in 80–85% yield. 
 
In RTIL: meso-2-cyclopenten-1,4-diol-isocyanate (S1) (0.050 g, 0.10 mmol), 
[Pd2(dba)3]·CHCl3 (0.005 g, 0.005 mmol) and elpan-phos- 2 (0.012 g, 0.015 
mmol) were vigorously stirred in RTIL (1 mL) under an inert atmosphere. 
After 30 min, the product was extracted with dry diethyl ether (3X15 mL) in 
70–80% yield and analyzed. Recycling was carried out by adding fresh 
substrate and triethylamine to the active catalytic solution.  
 
The enantiomeric excesses were determined by chiral HPLC, Chiracel OD-
H, 1:10 2-propanol/hexane, UV 254 nm, retention times: (–)-(R,S)-2: 22–24 
min; (+)-(S,R)-2: 30–32 min. The absolute configuration was obtained by 
comparison with a sample of known chirality. 
 
 
2.5.6 General procedure for the asymmetric allylic substitution of cis-
4-ciclopenten-1,3-dibenzoate (S2) with dimethylmalonate: 
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A solution of [Pd(μ-Cl)(η3-C3H5)]2 (0.0020 g, 0.0054 mmol), the ligand 
(0.016 mmol) and cis-4-ciclopenten-1,3-dibenzoate (0.083 g, 0.27 mmol) in 
1.0 mL of dry THF were stirred at 0°C for 0.2h under inert atmosphere. A 
solution of dimethylmalonate (31 μL, 0.27 mmol) and NaH (0.011 g) in 2.0 
mL of the same solvent at 0°C was added. After the desired time, the 
reaction was quenched by addition of methanol. Column chromatography on 
silica gel (1/2 ethyl acetate/hexane) gave the desired product as a white solid 
in 80–85% yield. The enantiomeric excesses were determined by chiral 
HPLC, Chiracel OD-H, 1:99 2-propanol/hexane, UV 254 nm, 1.0 mL/min, 
retention times: (1R,4S) 15.6 min, (1S,4R) 17.2 min. The absolute 
configuration was obtained by comparison with a sample of known chirality. 
 
 
2.5.7 General procedure for the asymmetric allylic substitution of cis-
4-ciclopenten-1,3-dibenzoate (S2) with N-benzylmethylamine: 
 
 
A solution of [Pd(μ-Cl)(η3-C3H5)]2 (0.0020 g, 0.0054 mmol), the ligand 
(0.016 mmol) and cis-4-ciclopenten-1,3-dibenzoate (S2) (0.083 g, 0.27 
mmol) in 1.0 mL of dry THF were stirred at 0°C for 0.2h under inert 
atmosphere. A solution of N-benzylmethylamine (35 μL, 0.27 mmol) and 
triethylamine (85 μL) in 2.0 mL of the same solvent at 0°C was added. After 
the desired time, the reaction was quenched by addition of 6.0mL of diethyl 
ether and 5mL of a solution of NaOH 2.0M. The organic phase was 
separated and extracted with a solution of NaHCO3 (sat, 1x5 mL), water 
(1X5mL) and brine (1X5mL), then anhydrified with sodium sulphate. 
Column chromatography on silica gel (1/4 ethyl acetate/hexane) gave the 
desired product as a white solid in 80–85% yield. The enantiomeric excesses 
were determined by chiral HPLC, Chiracel OD-H, 1:99 2-propanol/hexane, 
UV 254 nm, 1.0 mL/min, retention times: (-) 9.73 min, (+) 13.2 min.  
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2.5.8 General procedure for the asymmetric allylic substitution of cis-
4-ciclopenten-1,3-dibenzoate (S2) with phenol: 
 
 
A solution of [Pd(μ-Cl)(η3-C3H5)]2 (0.0020 g, 0.0054 mmol), the ligand 
(0.016 mmol) and cis-4-ciclopenten-1,3-dibenzoate (S2) (0.083 g, 0.27 
mmol) in 1.0 mL of dry THF were stirred at 30°C for 0.2h under inert 
atmosphere. A solution of N-benzylmethylamine (35 μL, 0.27 mmol) and 
NaH (0.011 g) in 2.0 mL of the same solvent at 30°C was added. After the 
desired time, solvent was evaporated. Column chromatography on silica gel 
(1/20 ethyl acetate/hexane) gave the desired product as a white solid in 80–
85% yield. The enantiomeric excesses were determined by chiral HPLC, 
Chiracel OD-H, 1:99 2-propanol/hexane, UV 254 nm, 1.0 mL/min, retention 
times: (+)-(1R,4S) 10.7 min, (-)-(1S,4R) 18.4 min. The absolute 
configuration was obtained on the basis of the optical rotatory power. 
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3. The elpaNpy ligands: Mo promoted Asymmetric 
Allylic Substitution promoted by microwaves. 
 
 
3.1 Background of the Mo promoted Asymmetric Allylic 
Substitution: scope of the reaction, mechanisms, state of the art. 
As mentioned in chapter 2, asymmetric allylic substitutions have been 
widely studied in recent years due to their high synthetic versatility. This 
feature arises from the variety of systems able to promote this reaction, 
because the stereo- and regiochemistry of the product are a function of the 
metal, the ligand, the nucleophile, and the substrate. This makes possible to 
access alternative reactivity by switching between different catalytic 
systems.  
Among them, those based on Pd have been most widely explored, but since 
Mo, W and Ir [1] catalysts exhibit complementary regiochemistry when 
unsymmetrically substituted allyl derivatives are used, catalysts containing 
these metals are valuable. Typically, Pd complexes afford the achiral linear 
products from monosubstituted allylic substrates, while Ir, W or Mo 
catalysts preferentially lead to the branched chiral products (Scheme 3.1). 
 
 
Scheme 3.1 
 
This section will focus on molybdenum as active metal center. The first Mo-
promoted allylic alkylation was reported in 1982 by by Trost and Lautens 
[2], but it took more than a decade to find suitable chiral catalysts. Up today, 
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this system have been used as key steps in enantioselective syntheses of 
several biologically active compounds.  
Molybdenum catalysts are generally less reactive than palladium ones in this 
reaction and rather high catalyst loadings are usually necessary, but efficient 
chiral ligands are available. At the same time, Ir complexes have a wider 
scope [3], but the cheap Mo catalyst precursors (typically Mo(CO)6, plus its 
derivates Mo(CO)3(EtCN)3 and Mo(CO)3(η
6
-C7H8)) are attractive due to 
theirs low cost and high stability [4]. Moreover, when AAA catalysed by Mo 
are performed under microwave irradiation (MW), Mo(CO)6 can be used 
directly without any pretreatment and the product is usually obtained in less 
than ten minutes with high regio- and stereoselectivity [5]. 
The scope of the reaction is fairly wide in terms of nucleophile, substrate, 
and leaving group [1b]: 
 
 Nucleophiles: The nucleophiles compatible with this system are 
stabilized carbon nucleophiles. Malonate esters are good 
nucleophiles in molybdenum-catalyzed allylations, and dimethyl 
malonate is the benchmark nucleophile for this reaction. Diketones 
and β-ketoesters react poorly, while a range of stabilized enolates 
exhibit high reactivity. 
 Substrates: The benchmark substrates rac-1-Aryl-2-propenyl 
methyl carbonate and cinnamyl methyl carbonate are readly 
available and the most commonly used. Allylic substrates with aryl 
and alkenyl substituents were reported, but resulted to be less 
reactive. Mo-catalyzed allylic alkylations are compatible with the 
presence of ketone, enone, ester, sulfone, acetal, olefin, alkyl halide, 
silyl, allyl ether, silyl ether, and enol ether functional groups. 
 Leaving groups: In Mo-catalyzed allylic alkylations allylic 
phosphates are more reactive than allylic carbonates, which are more 
reactive than allylic carboxylates. Usually branched allylic 
substrates are more reactive than their linear analogs.  
 
Among the several ligands used, the more efficients belong to bis-
pyridylamides family (L1 and L2 in Figure 3.1), readily obtained in one 
step by condensation of the desired carboxylic acid with the desired chiral 
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diamine. Alternative systems contains dihydrooxazole rings in place of 
pyridyl rings (L3 in Figure 3.1). 
 
 
 Figure 3.1 
 
These ligands have been used in a wide range of case-studies, and they 
represent the state of the art in terms of catalytic performances and 
applicability. Notable examples are the synthesis of α-amino acids using 
azlactones as nucleophiles [6] and the synthesis of Tipranavir, a nonpeptide 
HIV protease inhibitor [7]. (Scheme 3.2) 
 
Scheme 3.2 
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3.1.1 Mechanism and enantiodiscrimination 
 
Detailed mechanistic studies have been performed using the monopyridine 
ligand L4 of Scheme 3.3, where the catalytic cycle is reported [8]. The 
ligand  combines with the Mo source to yield the neutral Mo(0) complex C1, 
which then reacts with the substrate (linear or branched) to generate complex 
C2, an 18-electron η3-allyl Mo(II) complex with close to octahedral 
geometry. The stoichiometry for this reaction is: 
 
2 C1  + substrate  C2 + CO2 + MeOH + Mo(CO)6 + L4  
 
The addition of the substrate occurs with retention of configuration, and the 
ligand coordinates to the metal in a tridentate, fac-binding mode through the 
pyridine nitrogen, a deprotonated amide nitrogen and the benzamide oxygen. 
In the next step, the weakly bound amide carbonyl oxygen in 4 is replaced 
by a CO  with formation of C3, followed by coordination of malonate, 
leading to C4. Final reductive elimination yields the product and complex 
C5. In this step the coordinated nucleophile attacks the substrate with 
retention of configuration; the overall process occurs then with double 
retention.  
The η3-allyl complexes that are intermediates are rapidly equilibrating by the 
mechanisms reported in section 2.1.1 (π-σ-π isomerisation, apparent allyl 
rotation, M
0
-catalyzed alkyl exchange), which leads to the formation of a 
single major complex and thereby to high site- and stereoselectivity in the 
catalytic reactions. Equilibration of intermediate η3-allyl complexes is 
usually rapid in comparison to nucleophilc attack, and therefore almost the 
same mixtures of enantiomers and constitutional isomers are obtained from 
enantioenriched or racemic branched substrates as well as from linear 
substrates. 
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Scheme 3.3 
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In reactions with linear, achiral substrates, the catalyst may recognize one of 
the enantiotopic faces leading to selective formation of one of the 
diastereomeric η3-allyl complexes C6 or C7 (Scheme 3.4). Alternatively, the 
two complexes may be in dynamic equilibrium, with one of them being 
preferentially attacked by the nucleophile. Both situations may lead to 
efficient enantiodiscrimination. The equilibrium between C6 and C7 
proceeds mainly via η1-allyl Mo intermediates. 
 
 
Scheme 3.4 
 
Oxidative addition of the branched substrates (S)-S2 and (R)-S2 to the 
[MoL*] catalyst leads to complexes C6 and C7, respectively (Scheme 3.5). 
The absolute configuration of the product is determined by which one of 
these two complexes reacts with the nucleophile. Then, reaction of the 
branched racemic substrates would, in the absence of isomerization of 
intermediate allyl complexes, inevitably lead to the formation of racemates. 
If, in contrast, equilibration of the diastereomeric η3-allyl complexes is fast 
compared to nucleophilic attack, a dynamic kinetic asymmetric 
transformation (DYKAT)[9] results, which may lead to formation of a single 
enantiomer.  
 
 
Scheme 3.5 
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Branched substrates frequently react with somewhat lower enantioselectivity 
than the corresponding linear substrates, demonstrating that equilibration of 
the allyl complexes under certain conditions is not sufficiently rapid, 
resulting in a so called memory effect: the two diastereoisomers C6 and C7 
equilibrate via η3-η1-η3 isomerization, and if this process is slow compared to 
the nucleophilic attack, which also occurs by a syn mechanism, a memory 
effect may be observed, leading to lower enantioselectivity.  
 
 
3.1.2 State of the art: the Naplepy ligands. 
 
Within previous studies, the research group where this PhD thesis has been 
developed, contributed to the field of Mo-promoted asymmetric allylic 
substitution introducing the library of ligands naple-py [10], based on D-
glucose (Figure 3.1). This second subset of ligands can be considered as the 
sugar counterpart of the privileged DACH-py ligand. 
 
Figure 3.1 
This family of ligands finds its most effective application in the asymmetric 
allylic alkylation promoted by Mo and assisted by microwaves, where the 
product for the benchmark reactions was obtained with good yield and 
selectivity (Scheme 3.6), comparable with the results for the correspondent 
DACH-Py ligand.  
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Scheme 3.6 
 
 
3.2 the elpaNpy ligands: synthesis and characterization. 
 
In order to corroborate the strategy of pseudo-enantiomeric ligands (see 
chapter 1), the elpaN-py library was rationally designed, presenting a 
specular stereochemistry of coordination related to the Naple-py. According 
to the strategy mentioned before, within this study pseudo-enantiomeric 
ligands have been designed and prepared, aiming to produce the same Mo-
promoted asymmetric allylic substitution with opposite stereochemistry. 
In this section, the synthesis of the new subset of the elpaN-type bouquet 
(elpaN-Py series of Figure 3.2) is described; these ligands were applied in 
the Mo-catalysed AAA promoted by MW. 
 
Figure 3.2 
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The synthesis of the ligands is is reported in Scheme 3.7. The key 
intermediate in the synthesis of the ligands is the known 1-azido-2-
aminoglucose derivative 2 described in section 2, prepared from the bromide 
1 (step ii). 
The amino group of compound 2 was condensed with the desired acid (step 
iii), employing N,N'-dicyclohexylcarbodiimide (DCC) and 4-
dimethylaminopyridine (DMAP). Compound 3 was converted into the ligand 
by a Staudinger reaction, using PMe3 and the appropriate activated ester 
(step iv). This procedure is necessary because anomerization at C1 was 
usually observed when the azide was reduced to amine by H2 over Pd/C.  
Finally, the acetate groups of the elpaN-py ligand were conveniently 
deprotected by stirring a methanolic solution of the ligand in presence of 
ammonia to yield a ligand with free hydroxyl groups (step v). The 
deprotected ligand elpaN-py’ is soluble in water and ionic liquids (RTIL), 
but almost insoluble in DCM and toluene and was synthesized in order to 
explore the feasibility of a Mo promoted AAA under unconventional 
conditions. 
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Scheme 3.7 
 
The four ligands were fully characterized by 
1
H and 
13
C NMR spectroscopy, 
in order to confirm their structure and purity. The spectra are shown below. 
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1
H NMR spectrum of elpaN-py, 200 MHz, CDCl3 
 
1
H NMR spectrum of elpaN-py-p-OMe, 400 MHz, CDCl3 
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1
H NMR spectrum of elpaN-qui, 400 MHz, CDCl3 
 
 
1
H NMR spectrum of elpaN-py’, 400 MHz, D2O
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3.3 Catalytic performances of the elpaNpy ligands in the Mo 
promoted Asymmetric Allylic Substitution assistem by microwaves. 
 
The catalytic reactions (Scheme 3.8) were performed by using both a linear 
(S1) and a branched allylic carbonate (rac-S2) which, as mentioned before,  
are crucial substrates because the knowledge of their reactivity provides the 
necessary information for assessing the qualities of the ligands [8,11]. 
 
 
Scheme 3.8 
 
According to experimental conditions previously developed [10], Mo(CO)6, 
ligand, allylic carbonate S1, dimethyl malonate, and N,O-bis-
(trimethylsilyl)acetamide (BSA) were mixed in THF and heated at 160°C in 
the microwave cavity under air. After the desired reaction time, conversions 
and branched/linear ratios were determined by 
1
H NMR spectroscopy, and 
enantioselectivities by chiral HPLC.  
The different performances of the ligands were assessed by using 4 mol% of 
Mo catalyst, a ligand/metal ratio of 1.3:1 and a nucleophile/substrate ratio of 
1.1:1. The results of reactions of the linear substrate S1 are shown in Table 
3.1. As expected, Naple-type and elpaN-type ligands afforded products 
with opposite absolute configurations, the latter leading preferentially to the 
(S)-B product. Except for the ligand containing a quinoline group (entry 4), 
which was expected to be the less active and selective,
16 
good conversions, 
yields, regioselectivity, and stereoselectivity were observed. 
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Reaction conditions: dimethyl malonate (0.77 mmol), allylic carbonate rac-5 (0.71 
mmol),Mo(CO)6 (0.026 mmol, 4 mol%), ligand (0.034 mmol), BSA (208 μL), THF (2mL), 
160 °C, 6 min. aDetermined by NMR spectroscopy of the crude reaction mixture.  bYield of 
product isolated by column chromatography (EtOAc/petroleum ether=1/5). cDetermined by 
chiral HPLC Daicel OD-H (0.46 cm i.d. 25 cm) column. 
Table 3.1 
 
In analogy with the results obtained for the ligands derived from 1,2-
diaminocyclohexane,[11b] the presence of π-donating substituents in the 4-
position of the pyridyl rings increased the enantio- and site selectivity.[12] 
Thus, ligand elpaN-py-p-OMe was more selective than elpaN-py (entry 1 vs 
entry 2).  
A catalyst containing the deprotected ligand elpaN-py’ resulted in a similar 
activity, but lower regio- and stereoselectivity compared to the acetylated 
ligand (entry 1 vs entry 3). As expected, lower amounts of catalyst resulted 
in lower conversion and lower regioselectivity (entry 1 vs entry 5), although 
the enantioselectivity was still good (97% ee). 
Branched substrates, such as rac-S2, often react with lower 
enantioselectivity than their linear isomers as a result of the previously 
mentioned memory effect. The results for reactions of substrate rac-S2 are 
reported in Table 3.2. 
As expected, the branched substrate S2 resulted in lower enantio- and 
regioselectivity than the linear substrate, but still acceptable levels of 
enantioselectivity (88–96% ee (S)). Conversions observed for this substrate 
were lower but still good in all cases. The trend was analogous to that 
experienced for substrate S1, except that ligand elpaN-qui gave the highest 
branched/linear ratio (entry 4).   
 
 
 
N° 
elpaN-Py 
ligand 
Time  
[min] 
Cat. 
[mol%] 
Conv. 
[%]
[a]
 
Isolated yield 
[%]
[a]
 
B/L
[b] ee 
[%]
[c]
 
1 -py 6 4 94 65 14/1 98 (S) 
2 -py-p-OMe 6 4 92 70 25/1 99 (S) 
3 -py’ 6 4 100 72 6/1 97 (S) 
4 -qui 6 4 51 45 15/1 90 (S) 
5 -py-p-OMe 30 1 23 16 14/1 97 (S) 
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Reaction conditions: dimethyl malonate (0.77 mmol), allylic carbonate 4 (0.71 mmol), BSA 
(208 μL), THF (2 mL), 160 °C. aDetermined by NMR spectroscopy of the crude reaction 
mixture. bYield of product isolated by column chromatography (EtOAc/petroleum ether=1/5). 
cDetermined by chiral HPLC Daicel OD-H (0.46 cm i.d. 25 cm) column. 
Table 3.2 
 
The performance of ligand elpaN-py’ was also tested in water and in 
hydrophilic RTIL, taking advantage of its solubility in these solvents. 
Disappointingly, when water was used as solvent, the main product obtained 
from the allylic carbonate S1, as well as from the corresponding acetate, 
consisted of a mixture of the branched and linear alcohols. The hydrolysis 
was, at least in part, catalyzed by the metal complex as shown by the 
formation of only the linear product from the Mo-free background reaction, 
thus suggesting a π-allylic intermediate in the hydrolysis. In the ionic liquid 
bmimBF4, the allylic carbonate afforded the allylic ether in racemic form, 
mainly as product of a background decarboxylation, while the allylic acetate 
did not react.  
 
 
3.4 Conclusion. 
 
This work demonstrates the validity of a strategy, namely that it is possible 
to prepare libraries of pseudo-enantiomeric ligands from easily accessible 
natural compounds, with both synthetic and economic benefits.[13] 
In particular, the library elpaN-type, based on 1,2-disubstituted D-glucose, 
was expanded through the preparation of the bis(pyridine-2-carboxamide) 
derivatives elpaN-Py. The ligands were obtained in both protected and 
deprotected versions, and this has allowed to verify their ability in the AAA 
promoted by Mo under traditional and non-conventional conditions. High 
enantioselectivities were accomplished in the former case, starting from both 
N° Ligand Conversion [%]
[a]
 
Isolated 
yield 
[%]
[b]
 
B/L
[a] 
ee [%]
[c]
 
1 elpaN-py 94 72 17/1 96 (S) 
2 elpaN-py-p-OMe 78 66 21/1 95 (S) 
3 elpaN-py’ 73 55 6/1 86 (S) 
4 elpaN-qui 67 41 24/1 90 (S) 
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a linear and a branched allylic substrates. In water, although the 
enantioselective process was almost ineffective, a peculiar reactivity was 
disclosed, that could be the subject of further future research.  
 
 
3.5 Experimentals. 
 
3.5.1 General considerations: 
THF and toluene were dried by using a Glass-contour solvent dispensing 
system. Dichloromethane was distilled from CaH2. Microwave heating was 
performed by using a Smith Creator™ single-mode cavity from Biotage. 1H 
and 
13
C NMR spectra were recorded respectively at 400 or 200 MHz, and 
100.6 and 50.3 MHz. The 
1
H and 
13
C chemical shifts are reported using 
CHCl3 (for spectra recorded in CDCl3), HDO (for proton spectra recorded in 
water) or dioxane (for carbon spectra recorded in water) as internal 
standards. 
 
2.5.2 Synthesis of the activated esters, R = -Py and –Qui 
2-Pyridine carboxylic acid or 2-quinoline carboxylic acid (5.0 mmol), DCC 
(1.025 equiv), and N-hydroxysuccinimide (1.0 equiv) were suspended in 50 
mL of THF and the solution was stirred overnight. The suspension was 
filtered, and the solvent was evaporated under reduced pressure. The crude 
product was dissolved in DCM and precipitated by the addition petroleum 
ether. The resulting product was used without any further purification (yield: 
41 and 65% respectively, 0.46 g and 0.90 g). Activated Ester-Py: 
1
H NMR 
(400 MHz, CDCl3): 
3
J = 4.6 Hz, 1 H, aromatic), 8.21 (d, 
3
J  = 
7.8 Hz, 1 H, aromatic), 7.91 (td, 
3
J = 1.4 Hz, 
3
J = 7.8 Hz, 1 H, aromatic), 
7.59 (m, 1 H, aromatic), 2.92 (s, 4 H); 
13
C NMR (100.6 MHz, CDCl3): δ = 
169.24, 160.84, 150.91, 144.50, 137.72, 128.87, 127.05, 26.10. Activated 
Ester-Qui:
 1
H NMR (400 MHz, CDCl3): δ = 8.36 (d, 
3
J= 8.5 Hz, 1 H, 
aromatic), 8.31 (d, 
3
J = 8.6Hz, 1H, aromatic), 8.21 (d, 
3
J = 8.5 Hz,  1 H, 
aromatic), 7.92 (d, 
3
J = 8.2 Hz, 1 H, aromatic), 7.83 (t, 
3
J = 7.6 Hz, 1 H, 
aromatic),  7.71 (t, 
3
J = 7.5 Hz,  1 H, aromatic), 2.95 (s, 4H, ); 
13
C NMR 
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(100.6 MHz, CDCl3) δ = 169.00, 160.85, 147.87, 143.93, 137.74, 131.09, 
130.98, 129.94, 129.97, 127.80, 121.69, 25.86. R = -Py-p-OMe: The acid 
(5.0 mmol), DCC (2.5 equiv), and N-hydroxysuccinimide (1.1 equiv) were 
suspended in 130 mL of THF and the solution stirred overnight. The 
suspension was filtered, and the solvent was evaporated under reduced 
pressure. The crude product was extracted twice with boiling n-hexane in 
order to remove excess DCC. The solid was dissolved in EtOAc (50 mL), 
the solution was filtered, and then washed with EtOAc (2x25 mL). The 
solvent was removed under reduced pressure, leading to the crude product 
that was used with no further purification (yield: 580 mg, 45%). 
1
H NMR 
(400 MHz, CDCl3): δ = 8.65 (d, 
3
J = 5.7 Hz, 1 H, aromatic), 7.72 (d, 1 H, 
3
J 
= 2.4 Hz aromatic), 7.09 (dd, 
3
J = 2.5 Hz, 
3
J = 5.7 Hz, 1 H, aromatic), 3.94 
(s, 3 H, OMe), 2.91 (s, 4H); 
13
C NMR (100.6 MHz, CDCl3) δ = 171.86, 
186.99, 166.88, 160.57, 151.67, 141.43, 113.27, 55.99, 25.86. 
 
3.5.3 Synthesis of 3 
Compound 2 (1.32 g, 4.00 mmol) was dissolved in 25 mL of DCM (for the 
synthesis of 3-Py and 3-Qui) or 50 mL of THF (for the synthesis of 3-Py-p-
OMe). DMAP (0.0489 g, 0.40 mmol), the desired acid (4.20 mmol) and 
DCC (1.24 g, 6.00 mmol) were added in this order, and the solution was 
stirred for the desired time. DCU was removed by filtration, and the solution 
was concentrated under reduced pressure. The crude product was 
precipitated by slow addition of petroleum ether, and washed twice with the 
same solvent. The solid was extracted twice with boiling n-hexane and 
further purified by flash chromatography (silica/crude = 50/1 w/w). 
Product 
Reaction time 
(h) 
Eluent ratio 
(EtOAc/PE + 3% TEA) 
Yield 
(%) 
3-Py 2 1/1 68 
3-Py-p-OMe 18 3/1 57 
3-Qui 18 3/2 60 
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3-Py: 
1
H NMR (400 MHz, CDCl3): δ = 8.49 (d, 
3
J = 4.2 Hz, 1 H, aromatic), 
8.12 (d, 
3
JNH,2-H = 7.9 Hz, 1 H, NH), 7.79 (td, 
3
J = 1.4 Hz, 
3
J = 7.7 Hz, 1 H, 
aromatic), 7.39 (m, aromatic), 5.41 (t, 
3
J3-H,2-H = 
3
J3-H,4-H = 9.9 Hz, 1 H, 3-H), 
5.10 (t, 
3
J4-H,3-H = 
3
J4-H,5-H, 1 H, 4-H), 4.93 (d, 
3
J1-H,2-H = 9.2 Hz, 1 H,1-H), 
4.26 (dd, 
3
J6-H,5-H= 4.8 Hz, 
3
J6-H,6‗-H= 12.4 Hz, 1 H, 6-H), 4.15 (dd, 
3
J6‗-H,5-H= 
1.9 Hz, 1 H, 6‗-H), 4.03 (q, 1 H, 2-H), 3.81 (m, 1H, 5-H), 2.06 (s, 3 H, 
AcO), 1.98 (s, 3 H, AcO), 1.87 (s, 3 H, AcO); 
13
C NMR (100.6 MHz, 
CDCl3): δ = 170.83, 170.60, 169.54, 164.84, 148.90, 148.34, 137.61, 126.82, 
122.65, 88.69, 74.20, 72.03, 68.43, 62.03, 54.27, 34.09, 20.89, 20.75, 20.68. 
3-Py-p-OMe: 
1
H NMR (400 MHz, CDCl3): δ = 8.31 (d, 
3
J = 5.6Hz, 1 H, 
aromatic), 8.21 (d, 
3
JNH,2-H= 8.2 Hz, 1 H, NH), 7.69 (dd, 
3
J = 2.4 Hz, 
3
J = 
12.7 Hz, 1 H, aromatic), 6.92 (m, 1 H, aromatic), 5.46 (t, 
3
J3-H,2-H= 
3
J3-H,4-H = 
9.5 Hz, 1 H, 3-H), 5.14 (t, 
3
J4-H,3-H =  
3
J4-H,5-H, 1H, 4-H), 4.97 (d, 
3
J1-H,2-H= 9.2 
Hz, 1H, 1-H), 4.31 (dd, 
3
J6-H,5-H = 4.8Hz, 
3
J6-H,6‘-H = 12.4 Hz, 1 H, 6-H), 4.20 
(dd, 
3
J6‘-H,5-H= 2.1 Hz, 1 H, 6‗-H), 4.07 (q, 1 H, 2-H), 3.90 (s, 3H, OMe), 3.86 
(m, 1H, 5-H), 2.11 (s, 3H, AcO), 2.03 (s, 3 H, AcO), 1.93 (s, 3 H, AcO); 
13
C 
NMR (100.6 MHz, CDCl3) δ = 171.07, 170.82, 169.79, 167.42, 165.12, 
151.20, 149.70, 113.86, 108.07, 88.95, 74.47, 72.28, 68.75, 62.30, 56.14, 
55.95, 54.57, 35.31, 25.85, 25.07, 21.11, 20.98, 20.91. 3-Qui: 
1
H NMR (400 
MHz, CDCl3): δ = 8.35 (d, 
3
JNH,2-H= 9.0 Hz, 1 H, NH), 8.25 (q, 
3
J = 8.5Hz, 
2H, aromatic), 8.07 (d, 
3
J = 8.5 Hz,  1 H, aromatic), 7.83 (d, 
3
J = 8.1 Hz, 1 
H, aromatic), 7.73 (t, 
3
J = 7.7 Hz,  1 H, aromatic),  7.58 (t, 
3
J = 7.5 Hz,  1 H, 
aromatic), 5.51 (t, 
3
J3-H,2-H= 
3
J3-H,4-H= 9.9 Hz, 1 H, 3-H), 5.14 (t, 
3
J4-H,3-H = 
3
J4-
H,5-H, 1 H, 4-H), 5.02 (d, 
3
J1-H,2-H= 9.2 Hz, 1 H, 1-H), 4.30 (dd, 
3
J6-H,5-H = 
4.7Hz, 
3
J6-H,6‗-H = 12.4 Hz, 1 H, H-6), 4.17 (dd,  
3
J6‘-H,5-H= 1.8 Hz, 1 H, 6‘-H), 
4.09 (q, 1 H, 2-H), 3.86 (m, 1 H, 5-H), 2.09 (s, 3 H, AcO), 2.00 (s, 3H, 
AcO), 1.88 (s, 3H, AcO); 
13
C NMR (100.6 MHz, CDCl3) δ = 171.11, 170.87, 
169.83, 165.37, 148.97, 146.81, 138.06, 130.65, 130.24, 129.95, 128.64, 
128.14, 119.20, 89.00,  74.50, 72.27, 68.78, 62.31, 54.71, 34.36. 
 
3.5.4 Synthesis of the elpaN ligands 
The desired intermediate 3 (1.35 mmol) and the desired activated ester (1.25 
equiv) were dissolved in dry DCM (15 mL) under inert atmosphere. The 
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solution was cooled to -78 
o
C and a solution of 0.89 M PMe3 in dry toluene 
(1.25 equiv) was slowly added. The system was warmed to RT, and when 
evolution of N2(g) ceased, the reaction was quenched by the addition of 15 
mL of a saturated solution of Na2CO3 (aq). The organic phase was separated, 
and the water was extracted  with DCM (2x20 mL). The combined organic 
phases were dried over Na2SO4, filtered and concentrated under reduced 
pressure. The crude product was precipitated by slow addition of petroleum 
ether, and washed twice with the same solvent. The solid was purified by 
flash chromatography (silica/crude = 50/1 w/w). 
Product 
Eluent ratio 
(EtOAc/PE + 3% TEA) 
Yield 
(%) 
elpaN-Py 1/0 58 
elpaN-Py-p-OMe 1/0 41 
elpaN-Qui 2/1 67 
 
elpaN-Py: 
1
H NMR (400 MHz, CDCl3): δ = 9.06 (d, 
3
JNH,1-H = 9.6 Hz, 1 H, 
NH), 8.57 (d, 
3
J = 4.71 Hz, 1 H, aromatic), 8.31 (d, 
3
JNH,2-H = 9.6 Hz, 1H, 
NH), 8.03 (m, 2 H, aromatic), 7.70 (m, 2 H, aromatic), 7.33 (m, 2 H, 
aromatic), 5.57 (t, 
3
J1-H,NH = 
3
J1-H-2-H, 1 H, 1-H), 5.47 (t, 
3
J3-H,2-H =
3
J3-H,4-H = 10 
Hz, 1 H, 3-H), 5.24 (t, 
3
J4-H,3-H= 
3
J4-H,5-H, 1 H, 4-H), 4.58 (q, 1 H, 2-H), 4.36 
(dd,
3
J6-H,5-H = 4.21 Hz, 
3
J6-H,6‘-H = 12.4 Hz, 1 H, 6-H), 4.14 (dd, 
3
JH6‘,5-H= 2.0 
Hz, 1 H, 6‘-H), 3.96 (m, 1 H, 5-H), 2.09 (s, 3 H, AcO), 2.05 (s, 3H, AcO), 
1.94 (s, 3 H, AcO); 
13
C NMR (100.6 MHz, CDCl3) δ = 170.79, 169.51, 
165.26, 148.36, 148.19, 137.04, 126.56, 126.36, 122.63, 122.20, 79.89, 
73.72, 73.11, 68.29, 61.95, 52.92, 20.67. HRMS (ESI) calcd. for 
C24H26N4NaO9 [M + Na]
+
: 537.1597, found 537.1581. elpaN-Py-p-OMe: 
1
H 
NMR (200 MHz, CDCl3): δ = 8.97 (d, 
3
JNH,1-H= 9.3 Hz, 1 H, NH), 8.58 (d, 
3
J 
= 5.6 Hz, 1 H, aromatic), 8.22 (d, 
3
JNH,2-H = 9.4 Hz, 1 H, NH), 8.11(d, 
3
J = 
5.6 Hz, 1 H, aromatic), 7.57 (s, 1 H, aromatic), 7.51 (s, 1 H, aromatic), 6.80 
(m, 1 H, aromatic), 6.73 (m, 1 H, aromatic), 5.46 (t, 
3
J1-H,NH =  
3
J1-H,2-H, 1 H, 
1-H), 5.38 (t, 
3
J3-H,2-H =  
3
J3-H,4-H = 9.9 Hz, 1 H, 3-H), 5.17 (t, 
3
J4-H,3-H= 
3
J4-H,5-
H, 1 H, 4-H), 4.47 (q, 1 H, 2-H), 4.29 (dd, 
3
J6-H,5-H = 4.1Hz, 
3
J6-H,6‘-H= 12.4 
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Hz, 1 H, 6-H), 4.07 (dd, 
3
J6‘-H,5-H= 1.8 Hz, 1 H, 6‘-H), 3.90 (m, 1 H, 5-H), 
3.76 (s, 6 H, 2xOMe) 2.06 (s, 3H, AcO), 1.98 (s, 3 H, AcO), 1.88 (s, 3 H, 
AcO); 
13
C NMR (50.3 MHz, CDCl3) δ = 171.20, 171.12, 169.93, 167.09, 
165.68, 165.61, 151.13, 151.01, 149.92, 149.74, 113.62, 113.38, 108.32, 
108.02, 80.29, 74.12, 73.44, 68.74, 62.37, 55.89, 53.38, 34.36. HRMS 
(MALDI) calcd. for C26H30N4O11 [M]
+
: 574.1911, found 574.5331. elpaN-
Qui: 
1
H NMR (400 MHz, CDCl3): δ = 9.36 (d, 
3
JNH,1-H = 9.2 Hz, 1 H, NH), 
8.48(d, 
3
JNH,2-H = 9.5 Hz, 1 H, NH), 8.22 (d, 
3
J = 8.8Hz, 1 H, aromatic), 8.13 
(m, 2 H, aromatic), 8.02 (m, 2 H, aromatic), 7.83 (d, 
3
J= 8.5Hz, 1 H, 
aromatic), 7.73 (m, 2 H, aromatic), 7.65 (d, 
3
J = 8.8 Hz, 1 H, aromatic), 7.54 
(m, 2 H, aromatic), 7.45 (t, 
3
J= 7.5Hz, 1 H, aromatic), 5.66 (t, 
3
J1-H,NH = 
3
J1-
H,2-H, 1 H, 1-H), 5.54 (t, 
3
J3-H,2-H = 
3
J3-H,4-H= 9.9 Hz, 1 H, 3-H), 5.27 (t, 
3
J4-H,3-
H= 
3
J4-H,5-H, 1 H, 4-H), 4.69 (q, 1 H, 2-H), 4.37 (dd, 
3
J6-H,5-H= 4.2 Hz, 
3
J6-H,6‘-H 
= 12.4 Hz, 1 H, 6-H), 4.07 (dd, 
3
J6‘-H,5-H = 1.8 Hz, 1 H, 6‘-H), 3.90 (m, 1 H, 
5-H), 2.07 (s, 3 H, AcO), 2.04 (s, 3 H, AcO), 1.91 (s, 3 H, AcO); 
13
C NMR 
(100.6 MHz, CDCl3) δ = 171.24, 169.95, 166.02, 148.79, 148.73, 146.91, 
146.64, 137.67, 137.55, 130.68, 130.46, 130.40, 130.35, 129.83, 129.61, 
128.59, 128.43, 127.89, 127.76, 119.27, 119.00, 80.64, 74.29, 73.55, 68.81, 
62.43, 53.58. HRMS (ESI) calcd. for C32H31N4O9 [M + H]
+
: 615.2091, found 
615.2041. 
 
3.5.5 Synthesis of elpaN-py’ 
The elpaN-py ligand (0.50 mmol) was dissolved in MeOH (10 mL) under a 
NH3 atmosphere. After 20 h the solvent was removed under vacuum, 
affording the pure product as a solid in quantitative yield. Relevant NMR 
data: elpaN-Py’: 1H NMR (400 MHz, D2O): δ = 8.42 (m, 2 H, aromatic), 
7.75 (m, 2 H, aromatic), 7.41 (m, 2 H, aromatic), 5.37 (d, 
3
J1-H,NH = 
3
J1-H-2-H= 
9.65 Hz, 1 H, 1-H), 4.18 (t, 
3
J2-H,NH = 9.93 Hz, 1 H, 2-H), 3.81 (m, 2H, 6-H 
and 3-H), 3.70 (dd, 
3
J6‘-H,5-H=  4.9 Hz, 1H, 6‘-H), 3.58 (m, 2 H, 5-H and 4-
H); 
13
C NMR (100.6 MHz, D2 171.01, 170.51, 151.82, 151.64, 
151.34, 150.67, 141.20, 130.58, 130.22, 125.68, 125.46, 81.95, 80.77, 76.82, 
72.54, 63.49, 57.76. HRMS (ESI) calcd. for C18H20N4NaO6 [M + Na]
+
: 
411.1281, found 411.1279. 
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3.5.6 Microwave-assisted allylic alkylations.  
General procedure: two different stock solutions were prepared: solution N, 
containing the nucleophile, was prepared by adding dimethyl malonate (880 
μL, 7.7 mmol) to a suspension of 60% NaH in mineral oil in tetrahydrofuran 
(10 mL), and solution S, containing the substrate, was prepared by 
dissolving the allylic carbonate (S1 or S2) (7.1 mmol) in THF (10 mL). Then 
the appropriate ligand (0.034 mmol) and Mo(CO)6 (6.9 mg, 0.026 mmol) 
were transferred to a flame-dried SmithProcess VialTM. Solution N (1 mL), 
solution S, and BSA (208 μL) were added in this order, and the suspension 
was heated in the microwave cavity at 160 °C for the desired time. The 
brown solution obtained was diluted with Et2O to a total volume of 10 mL, 
resulting in a dark precipitate. A sample of the solution was filtered through 
silica gel and analysed by 
1
H NMR spectroscopy to determine the 
conversion and the regioselectivity. The crude product was then purified by 
chromatography on silia gel (eluent: petroleum ether/EtOAc, 5/1). The ee 
was determined by HPLC using a Daicel OD-H (0.46 cm i.d. 25 cm) 
column. The structures of the products were confirmed by comparison with 
published spectroscopic data. 
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4. The elpaN-salen ligands: [Mn-salen] promoted 
Asymmetric Epoxidation. 
 
 
4.1 Background of the Mn-salen promoted Asymmetric Epoxidation: 
scope of the reaction, mechanisms, state of the art. 
The asymmetric epoxidation of olefins is of great interest because the 
resulting optically active epoxides are valuable intermediates for a wide 
variety of pharmaceutically relevant compounds; [1] various nucleophiles 
react with epoxides stereospecifically to give 1,2-difunctionalized products, 
establishing the stereochemistry of two vicinal carbons.  
The pioneering studies on Asymmetric Epoxidation (AE) were performed on  
allylic alcohols and have been reported by Yamada [2] and Sharpless [3], 
independently. In 1980, a highly enantioselective epoxidation of allylic 
alcohols promoted by Titanium tartrate was first reported  by Katsuki and 
Sharpless [4].  
The enormous success of the Sharpless epoxidation reaction, which was 
awarded of the Nobel Prize in 2001, helped inspire widespread efforts to 
identify more general catalytic systems which might be effective for AE of 
unfunctionalized olefins, but efficient catalysts were designed only relatively 
recently [5]. The rational design of these catalyst was performed on the basis 
of the analogy with several stereoselective biological oxidation systems [6], 
and is based on highly enantioselective oxo-transfer [7]. Among them, Mn-
salen complexes play a key role, but also Fe- and Mn-porphyrine are widely 
used [1b]. More recently, chiral dioxiranes have been developed as effective 
epoxidation catalysts, widening the substrate scope [8]. The following 
section will focus mainly on the Mn-salen complexes. 
The generic AE promoted by Mn-salen is reported below in Scheme 4.1. 
The neat reaction is the simple formation of an epoxide starting from a 
double bond; a stochiometric oxidant is necessary, and usually additives 
increase the selectivity of the reaction.  
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Scheme 4.1 
 
The scope of the reaction is wide in terms of substrate, oxidant and 
additives: 
 
 Substrates: Cyclic and acyclic cis-disubstituted olefins have 
traditionally been the best substrates for the [Mn(salen)]-catalyzed 
epoxidation reaction; also trans-disubstituted olefins can be used, 
although progress in this area has been limited. Alternative methods 
exist to promote the epoxidation of cis-olefins to trans-epoxide as 
the major, and in some cases nearly exclusive, product [9]. A wide 
range of trisubstituted olefins are outstanding substrates for 
asymmetric epoxidation [10]. For monosusbstituted olefins, such as 
styrene, diminished catalyst enantioselectivity is reported, for then 
less using low-temperature protocol; improved enantioselectivities 
were attainable for most substrates under low-temperature 
conditions, but the effect was especially pronounced in the case of 
terminal olefins.[11]  
 Oxidants: A extensive variety of stoichiometric oxidants have been 
recognized to be effective oxygen atom donors in oxo-transfer 
reactions with the catalysts.  NaOCl [12] is problaly the most used, 
but alternatives are alkyl hydroperoxides [13], peroxy acids [14], 
amine N-oxides [15], ozone [16], potassium hydrogen persulfate 
(Oxone) [17], hydrogen peroxide [18], and periodate [19]. 
 Additives: In many cases, the addition of Lewis bases has been 
found to have a beneficial effect on catalyst activity and selectivity, 
probably due to coordination of the metal centre. Commonly used 
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additives include pyridine, imidazole, and pyridine N-oxide 
derivatives.  
 
The generic structure of the salen ligands, reported in Figure 4.1a, 
incorporate a dissymmetric diimine bridge, derived from a C2-symmetric 
1,2-diamine, and bulky substituents on the 3- and 3'-positions of the 
salicylide ligand. Several variants of this system exist.  
 
Figure 4.1 
 
The most used ligands is based on 1,2-trans-cyclohexandiamine and the 3,5-
di-tert-butyl salycilaldehyde (Figure 4.1b), due to a good compromise 
between selectivity and synthetic accessibility, although it is not the most 
selective.  
L1 has been employed widely on both laboratory and industrial scales for 
the epoxidation of cis-disubstituted and trisubstituted olefins, and its 
synthesis has been commercialized on the multi-hundred kg scale  [20]. A 
notable example of its use in synthesis of Duocarmicyn SA, an antitumour 
antibiotics (Scheme 4.2).[21]   
 
 
Scheme 4.2 
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4.1.1 Mechanism and enantiodiscrimination 
 
As mentioned before, the mechanism of AE promoted by [Mn(salen] goes 
thought oxo-transfer from metal complexes to olefins, resulting in a net two-
electron reduction at the metal center. For this reason, only metals capable of 
shuttling between oxidation states can be effective oxo-transfer catalysts, 
such as iron, manganese, ruthenium, and chromium [22]. The more widely 
accepted mechanism, typical for AE with tetradentate porphyrin and salen 
ligand frameworks, is reported in Scheme 4.3.  
 
 
Scheme 4.3 
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The square planar Mn
III
 complex C1 is oxidized to the correspondent oxo-
specie C2, which is attacked directly by the substrate with sequential C-O 
bond formation. The olefin approachs to the Mn-O bond by a side-on, 
perpendicular trajectory. The radical C3 can lead to the cis epoxide, or can 
isomerize to C4 by rotation on the σ bond; this specie is responsible for the 
formation of the trans-epoxide. The extent of trans-epoxide formation 
depends strongly on the nature of the substrate: it is negligible for alkyl-
substituted cis-olefins, it is more evident for aryl-substituted cis-olefins, 
while is prevalent for conjugated dienes. Additives such as pyridine N-oxide 
positively influence the rate, yield, cis/trans ratio, and enantioselectivity of 
the [Mn(salen)]-catalyzed epoxidation because the binding of N-oxide to the 
manganese center is thought to facilitate the rate-limiting oxidation to the 
metal-oxo, as well as stabilize the high-valent Mn(V) species.  
The origin of enantioselectivity is explained on the basis of the active oxo-
specie conformation. [23] The stepped conformation of Figure 4.2 is 
reported to be the more stable.  
 
 
 
Figure 4.2 
 
As mentioned before, the olefin will approach side-on to this ―lenticular‖ 
molecule; several trajectories are possible (i-v in Figure 4.3, where the 
system is reported from above) but all of them, except iv, are reported to be 
unfeasible due to steric interaction between the olefin and the ligand; in 
particular, i is inhibited for the stepped conformation, ii and iii for the 
interaction with the cyclohexyl moiety, v for the interaction with the tBu 
groups. Enantioselectivity originates from the substrate approaching trough 
iv preferentially from only one  enantioface, namely the one which minimize 
the steric interaction between the bulkier group RL on the alkene and the 
hindered group in position 3 of the salylicaldehyde. 
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Figure 4.3 
 
4.1.2 State of the art: the Naple-salen ligands. 
 
This further ―bouquet‖ of ligands, prepared in the research group where this 
PhD thesis has been performed [24], expanded the scope of the previously 
mentioned Naple-type ligands and contains the coordinating functions of the 
privileged salen ligands, namely two iminohydroxyphenyl arms in adjacent 
positions (Figure 4.4). 
 
Figure 4.4 
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The  cationic N,N’,O,O’-Mn(III) complexes of the doubly deprotonated 
ligands were prepared and investigated in this important asymmetric reaction 
affording chiral epoxides.  
A preliminary screening under four different conditions (with m-
chloroperbenzoic acid, H2O2, NaClO and  oxone) allowed to select the best 
oxidizing conditions, which were found in the use of m-chloroperbenzoic 
acid in the presence of N-methylmorpholine oxide at 195K in DCM. As 
shown in Scheme 4.4, (1S,2R)-P1 was obtained in excellent yield, high 
selectivity and good ees. These values are close to that obtained by using the 
original Jacobsen catalyst under the same experimental conditions.    
 
Scheme 4.4 
 
Analogously, styrene was reacted with acceptable selectivities. 
The possibility to extend use of the catalysts to multi-phasic catalysis was 
explored, by preparing a homogenous supported version of Mn(Naple-salen-
1)]PF6 [24b] (Figure 4.5). 
 
Figure 4.5 
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The supported catalyst was prepared again by anchorage to the Stratosphere-
CHO resin through the ring positions C4 and C6. It was found to contain 
0.16–0.18 mmol of Mn per gram, and was examined in the epoxidation of 
cis-β-methylstyrene under the above mentioned conditions. Signiﬁcant leak 
of metal from the matrix occurred during its use, which prevented efﬁcient 
re-cycling of the catalyst.  
 
 
4.2 the elpaN-salen ligands and the corresponding Mn complexes: 
synthesis and characterization. 
 
In order to fully employ the versatility of the approach of pseudo-
enantiomeric ligands (see chapter 1), the library of ligands elpaN-salen was 
rationally designed. This shows a specular stereochemistry of coordination 
related to the Naple-salen, aiming to produce the same Mn-promoted 
asymmetric epoxidation with opposite stereochemistry. 
Scheme 4.5 reports the simple synthesis of the elpaN-salen-H2 ligands 
along with their labels. 
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elpaN-salen-aH2: R= R1= t-Bu, R2= H
elpaN-salen-bH2: R= R1= H, R2= t-Bu
elpaN-salen-cH2: R= R1= R2= t-Bu
elpaN-salen-dH2: R1= H, R= R2= t-Bu
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O
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AcO
AcO
AcO
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(i)
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H2N N3
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AcO
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(ii)
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N N3
AcO
AcO
AcO
OHR
R2
3a: R= H, R2= t-Bu
3b: R=R2= t-Bu
(iii)
(i) THF, Me3SiN3, t-BuOK, -KBr, -t-BuOSiMe3 
(ii) toluene, ArCHO, -H2O; 
(iii) toluene, PMe3, ArCHO, -N2, -OPMe3; 
(iv) MeOH, KOH
O
N N
HO
HO
HO
OH HO
t-Bu t-Bu
(iv)
elpaN-salen-c'H2
t-But-Bu
 
Scheme 4.5 
 
The key-intermediate was the previously mentioned 1-azido-2-aminoglucose 
derivative 2, which 2 could be reacted with the appropriate salicylaldehyde 
ArCHO (step ii), affording the 2-iminoderivatives 3a-b. Condensation with a 
second equivalent of aldehyde (via Staudinger reaction, step iii) provided the 
target ligands. Steps ii and iii could be conveniently performed in one pot, 
although the syntheses of elpaN-salen-dH2 and –eH2 required isolation in 
the solid state of the intermediates 3b and 3a. 
The five ligands differ for the position and the number of t-butyls in 
positions 3‘ and 5‘ of the aromatic portions. All of them, with the exception 
of elpaN-salen-aH2, show tactical t-Bu groups in 3‘, i.e. ortho to the 
alcoholic oxygen. This steric motif is acknowledged as essential requirement 
for promoting high ees in the asymmetric epoxidation of styrenes promoted 
by the corresponding Mn(III) complexes. 
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ElpaN-salen-bH2 and –cH2 are symmetrically substituted: the former shows 
only the just mentioned t-butyls in 3‘, the latter displays subsidiary t-butyls 
in the 5‘-positions of both imino arms.  
Instead, elpaN-salen-dH2 and –eH2 do present only one additional t-butyl 
group in 5‘, respectively in the imino function at C2 (elpaN-salen-dH2) and 
C1 (elpaN-salen-eH2).  
This set of ligands was selected and prepared for assessing primary and 
secondary effects of the steric hindrance around the metal center, as well for 
disclosing possible enhancement of enantioselectivity due to selective 
crowding at only one side of the ligand. 
A deprotected ligand (elpaN-salen-c’H2) was also prepared, by treatment of 
the parent compound with catalytic potassium hydroxide in methanol (step 
iv). This action returned the hydroxyl functions available for further 
functionalization, and such a possibility was exploited for assessing the 
effect of other coordinating functions on the outcome of the catalysis.   
The characterisation of the ligands was carried out through elemental 
analysis, IR and NMR spectroscopy. Deuterobenzene was used as solvent 
for NMR measurements, in order to inhibit hydrolysis of the imino 
functionalities, which takes place more easily in the acidic chlorinated 
solvents. As expected, the CH=N protons resonated at high frequency, as 
well as the –OH nuclei which were detected in the range 12-14 ppm. As an 
exemple, the 
1
HNMR spectrum of elpaN-salen-bH2 is reported. 
The absorptions at ca. 1630 cm
−1
 in the IR spectra recorded in nujol mull 
were attributed to the C=N stretchings. 
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1
H NMR spectrum of elpaN-salen-bH2, 400 MHz, C6D6 
 
 
 
 
 The X-ray structure of elpaN-salen-bH2 was also determined (Figure 
4.6). 
 
Figure 4.6 
90 
 
All bond distances fall in the normal range [25]. In the molecule the sugar 
ring adopts the expected chair conformation and the substituents at C2, C3, 
C4, C5, C6 occupy the equatorial positions. A planar conformation of both 
the phenoxyimine groups is stabilized by intramolecular OH
…
N hydrogen 
bonds (O8-H
…
N1 0.968(7), 1.821(6) Å, 130.8(4)°; O9-H
…
N2 1.023(6), 
1.610(6) Å, 155.2(4)°).  An angle of 71.4(2)° is observed between their 
mean planes. In the crystal packing weak C-H∙∙∙∙O interactions favour the 
sugar rings to pile up along b axis, forming layers of molecules 
perpendicular to c axis. The layers of molecules face each to the other 
through hydrophobic t-butylic contacts. 
Cationic manganese(III) complexes (Figure 4.7) were prepared from 
Mn(AcO)2 through a known established procedure and according to the 
following illustrative stoichiometry, where elpaN-salen-a indicates the 
doubly deprotonated form of elpaN-salen-aH2: 
2 [Mn(AcO)2] + 1/2 O2 + 2 elpaN-salen-aH2 + 2 NaPF6 =  
2 [Mn(elpaN-salen-a)]PF6 + 2 
NaOAc + 2 HOAc + H2O 
 
Figure 4.7 
Only in the case of elpaN-salen-c’H2 was found more convenient the 
isolation of the neutral hydroxospecies [Mn(OH)(elpan-salen-c’)], which 
was expected to show a very similar catalytic behaviour.  
The dark brown compounds were soluble in chlorinated solvents and 
aromatic hydrocarbons, and were characterised through elemental analysis, 
conductivity measurements, MS and IR spectroscopy. The molar 
conductivity of the cationic species in dichloromethane is within the range 
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20-25 S-1cm2mol-1, which confirms that they are 1:1 electrolytes.[26]  
The IR CH=N stretchings are at lower frequencies with respect to those 
observed for the parent ligands. The PF6
-
 anion gives rises to the expected 
broad band at ca. 850 cm-1. 
 
 
4.3 Catalytic performances of the elpaN-salen ligands in the Mn 
promoted Asymmetric Epoxidation. 
 
The ability of the new sugar based Mn complexes to promote the 
asymmetric epoxidation of styrenes was examined, also in comparison with 
the Naple-type counterpart. 
First, epoxidation of cis-β-methylstyrene was carried out under diverse 
conditions by using [Mn(elpaN-salen-b)]PF6 as catalyst. This screening was 
necessary in order to find out the best conditions for the catalysis, and the 
results are shown in Table 4.1.  
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N° Oxidant t (h) Conversion(%)
a
  cis/trans ee(%)
b
 
1 m-CPBA
c
 0.5 >99 92/8 84(1R,2S) 
2 NaClO
d
 4.5 >99 88/12 68(1R,2S) 
3 n-Bu4NHSO5
e
 4.5 >99 71/29 50(1R,2S) 
4 H2O2
f
 4.5 - - - 
aThe conversion was calculated by integration of suitable peaks in NMR spectrum; bThe 
determination of ees was carried out by 1H NMR analysis in CDCl3 in the presence of 
Eu(hfc)3 as shift reagent. The ees refer to the cis-epoxide. 
cAt 196 K, in dichloromethane (4 
mL). Ingredients (mmol): Mn/alkene/m-CPBA/NMO= 0.024/0.48/0.96/2.40. dAt 273K in 
dichloromethane/water(pH 11.5) 1:2 (3 mL). Ingredients (mmol): Mn/alkene/NaClO(0.4 
M)/py-N-oxide= 0.024/0.48/1.00/0.072. . eAt 255 K in acetonitrile (3 mL). Ingredients 
(mmol): Mn/alkene/(n-Bu4N)HSO5/NMO= 0.024/0.48/0.75/0.48 
fAt 273 K in 
acetonitrile/acetic acid 16:1 (8 mL). Ingredients (mmol): Mn/alkene/H2O2(35%)= 
0.024/0.48/1.00 
Table 4.1 
 
Satisfactory results were obtained in dichloromethane at 196 K, by using m-
chloroperbenzoic acid (m-CPBA) as the oxidant in the presence of N-
methylmorpholine-N-oxide (NMO). In these conditions, the catalyst (entry 
1) afforded the cis epoxide (cis/trans 92/8) as major product, with high 
conversions (>99% within 30 mins) and good ee (84%, 1R,2S). An important 
outcome of this reaction is that the product was obtained with similar 
enantiomeric excess but opposite configuration with respect to what found 
by using the corresponding Naple-type derivative [24] (86%, 1S,2R).  
On the other hand, use of NaClO or oxone (entries 2 and 3) was 
accompanied by reduced cis/trans ratios (respectively 88/12 and 71/29) and 
moderate enantioselectivities (respectively 68% and 50%).   
Hydrogen peroxide failed to promote the reaction. 
Once found the optimal reaction conditions, cis-β-methylstyrene was 
oxidised with m-CPBA by using the entire set of ligands (Table 4.2). 
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N° ligand t (h) conversion
b
 cis/trans ee(%)
c
 
1 elpaN-salen-b 0.5 99 92/8 84(1R,2S) 
2 elpaN-salen-c 0.5 99 92/8 88(1R,2S) 
3 elpaN-salen-d 0.5 99 90/10 82(1R,2S) 
4 elpaN-salen-e 0.5 99 92/8 86(1R,2S) 
5 elpaN-salen-c’d 0.5 >99 88/12 83(1R,2S) 
a
At 196 K, in dichloromethane (4 mL). Ingredients (mmol): Mn/alkene/m-
CPBA/NMO= 0.024/0.48/0.96/2.40. 
b
The conversion was calculated by integration 
of suitable peaks in NMR spectrum. 
c
The determination of ees was carried out by 
1
H 
NMR analysis in CDCl3 in the presence of Eu(hfc)3 as shift reagent. The ees refer to 
the cis-epoxide. 
d
The catalyst was the neutral hydroxospecies [Mn(OH)(elpaN-
salen-c’)]  
Table 4.2 
 
As expected, complex [Mn(elpaN-salen-a)]PF6, which lacks of the strategic 
t-butyl groups in 3‘, failed to promote any enantioselectivity. All the other 
complexes afforded the cis product in reasonable selectivity and good ees 
(up to 88% ee), with little differences due to the diverse distributions of the 
subsidiary t-butyls in 5‘. Good levels of enantioselectivity were observed 
also with the deprotected ligand elpaN-salen-c’, which demonstraates that 
decoration of the ligand does not affect its performance. 
The discrepancies are very small, and therefore not sufficient to establish 
secondary effects on the stereochemical outcome of the reaction. However, 
this screening at least allowed to identify the most efficient catalyst, namely 
[Mn(elpaN-salen-c)]PF6 (Table 3). 
This compound was therefore also used for promoting epoxidation of other 
styrenes in the same conditions: styrene and β-methylstyrene were 
functionalised respectively in 45% and 50% ees. These findings are in 
agreement with literature data, because the oxidation of terminal olefins 
promoted by Mn salen complexes generally proceeds with lower 
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enantioselectivity. For instance, under the same experimental conditions the 
corresponding Jacobsen catalyst promotes the epoxidation of styrene in 56% 
ee [27]. 
Finally, the reaction on cis- and trans-stilbene provided the trans-oxide as a 
racemate. While these latter findings are not as satisfactory, the ensemble of 
results herein described significantly upgrade those obtained with the other 
rare examples of Mn(III)/ salen complexes derived from carbohydrates [28].  
 
 
4.4 Conclusion. 
 
This work substantiates the original idea on the possibility to prepare 
libraries of pseudo-enantiomeric ligands based on D-glucose by simply 
switching the positions of coordination from C2 and C3 (Naple-type) to C1 
and C2 (elpaN-type). Thus, the series of elpaN-salen-H2 ligands was 
prepared through a straightforward synthesis starting from inexpensive 
sources. The Mn(III) complexes of the corresponding O,O’-deprotonated 
chelates were found to be active in the asymmetric epoxidation of styrenes. 
A comparison with the enantiomeric Naple-type counterpart, returns a 
gratifying view about the performance of the new complexes. The next 
application will concern the extension to multiphase catalysis [29], using 
appropriate phase-tags on the auxiliary sugar positions at C3, C4 and C6. 
 
 
4.5 Experimentals. 
 
4.5.1. General consideration: 
 
NMR spectra were recorded in CDCl3 (CHCl3, δ = 7.26 ppm, and 
13
CDCl3 δ 
= 77 ppm, as internal standards), or C6D6 (TMS, δ = 0 ppm, and 
13
C6D6 δ = 
128.62 ppm, as internal standards) with a 400 MHz (Bruker DRX-400). J 
values are given in Hz. Dichloromethane was distilled from CaH2, toluene 
from Na.  
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4.5.2. Preparation of elpaN-salen-aH2, -bH2, -cH2: 
  
Azide 2 (0.66 g, 2.0 mmol) was stirred in dry toluene (8.0 mL) under inert 
atmosphere at 273 K. The desired aldehyde was added (4.2 mmol), followed 
by P(Me)Ph2 (0.40 g, 2.0 mmol). The system was stirred over night at RT. 
The solvent was removed under vacuum and the crude product was purified 
by flash cromatography on silica (eluent: EtOAc / PE =1/3, NEt3 1%) elpaN-
salen-aH2: MS(MALDI) calcd. for C34H45N2O9 [LH]
+
: 625.31, found 
625.40- 
1
H NMR(C6D6): δH = 12.62 (1 H, s, OH),  12.53 (1 H, s, OH), 8.37 
(1 H, s, N=CH) 8.03 (1 H, s, N=CH), 7.29-7-05 (5 H, m, aromatics), 6.94 (1 
H, d, J = 6.9, aromatic) 5.67 (1 H, t, J3,4 = J3,2 = 9.7, 3-H), 5.42 (1 H, t, J4-5 = 
9.7, 4-H), 4.50 (1 H, dd, J6,6‘  = 12.3, J5,6 = 4.7, 6-H), 4.46 (1 H, d, J1,2 = 8.6, 
1-H), 4.22 (1 H, dd, J5,6‘ = 1.2, 6‘-H), 3.57 (1 H, m, 5-H), 3.18 (1 H, t, 2-H), 
1.80 (3 H, s, OAc), 1.77 (3 H, s, OAc), 1.55 (3 H, s, OAc), 1.17 (9 H, s, t-
Bu), 1.12 (9 H, s, t-Bu). 
13
C NMR(C6D6): δC = 170.2, 170.1, 169.6, 169.4, 
165.9, 159.8, 159.7, 141.6, 141.5, 131.2, 131.1, 129.1, 128.7, 118.2, 118.1, 
117.6, 117.5, 92.1, 74.8, 74.7, 74.4, 68.8, 62.4, 34.0, 33.9, 31.5 (6C), 20.5, 
20.4, 20.1; IR: νmax/cm
−1
 = 1751 (C=O), 1635 (C=N). elpaN-salen-bH2: 
MS(MALDI) calcd. for C34H45N2O9 [LH]
+
: 625.31, found 625.43. 
1
H 
NMR(C6D6): δH = 13.45 (1 H, s, OH),  13.44 (1 H, s, OH), 8.30 (1 H, s, 
N=CH) 7.95 (1 H, s, N=CH), 7.29 (2 H, t, J = 8.6, aromatics), 6.94 (1 H, d, J 
= 6.9, aromatic), 6.86 (1 H, d, J = 6.9, aromatic), 6.74 (1 H, t, J = 6.7, 
aromatic), 6.67 (1 H, t, J = 6.7, aromatic), 5.64 (1 H, t, J3,4 = J3,2 = 9.7, 3-H), 
5.40 (1 H, t, J4-5 = 9.7, 4-H), 4.50 (1 H, dd, J6,6‘  = 12.4, J5,6 = 4.6, 6-H), 4.41 
(1 H, d, J1,2 = 8.6, 1-H), 4.21 (1 H, dd, J5,6‘ = 1.5, 6‘-H), 3.57 (1 H, m, 5-H), 
3.03 (1 H, t, 2-H), 1.82 (3 H, s, OAc), 1.81 (3 H, s, OAc), 1.57 (3 H, s, 
OAc), 1.56 (9 H, s, t-Bu), 1.49 (9 H, s, t-Bu). 
13
C NMR(C6D6): δC = 170.6, 
170.2, 169.6, 169.4, 166.2, 161.0(2C), 138.0(2C), 131.1, 131.0(2C), 130.9, 
118.8, 118.7(3C), 92.0, 74.6, 74.2, 74.1, 68.8, 62.3, 35.2, 35.2, 29.7(3C), 
29.6(3C), 20.4, 20.3, 20.1.; IR: νmax/cm
−1
 = 1752 (C=O), 1629 (C=N). elpaN-
salen-cH2: MS(MALDI) calcd. for C42H61N2O9 [LH]
+
: 737.44, found 
737.50. 
1
H NMR(C6D6): δH = 13.38 (1 H, s, OH),  13.30 (1 H, s, OH), 8.37 
(1 H, s, N=CH) 8.03 (1 H, s, N=CH), 7.56 (1 H, s, aromatic), 7.54 (1 H, s, 
aromatic), 7.07 (1 H, s, aromatic), 7.00 (1 H, s, aromatic), 5.70 (1 H, t, J3,4 = 
J3,2 = 9.7, 3-H), 5.43 (1 H, t, J4-5 = 9.7, 4-H), 4.50 (1 H, dd, J6,6‘  = 12.3, J5,6 = 
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4.6, 6-H), 4.46 (1 H, d, J1,2 = 8.6, 1-H), 4.21 (1 H, dd, J5,6‘ = 1.5, 6‘-H), 3.59 
(1 H, m, 5-H), 3.17 (1 H, t, 2-H), 1.80 (3 H, s, OAc), 1.77 (3 H, s, OAc), 
1.61 (9 H, s, t-Bu), 1.58 (3 H, s, OAc), 1.54 (9 H, s, t-Bu), 1.31 (9 H, s, t-
Bu), 1.23 (9 H, s, t-Bu). 
13
C NMR(C6D6): δC = 171.0, 170.2, 169.7, 169.5, 
166.8, 159.0, 158.9, 140.8(2C), 137.5, 137.4, 127.5(2C), 127.0(2C), 118.3, 
118.2, 92.1, 74.7, 74.5, 74.3, 68.9, 62.4, 35.5(2C), 34.4, 34.3, 31.7(3C), 
31.6(3C), 29.8(6C), 20.5, 20.4, 20.2. IR: νmax/cm
−1
 = 1752 (C=O), 1628 
(C=N).  
 
 
4.5.3 Preparation of 3a-b: 
 
Azide 2 (0.66 g, 2.0 mmol) was stirred in dry toluene (8.0 mL) under inert 
atmosphere. The desired aldehyde was added (2.0 mmol), and the system 
was left to react over night. The solvent was removed under vacuum and the 
crude product was purified by flash cromatography on silica gel (eluent: 
EtOAc/PE =1/2, NEt3 1%) 3a: 
1
H NMR(C6D6): δH = 13.22 (1 H, s, OH), 
8.03 (1 H, s, N=CH), 7.62 (1 H, d, J = 2.3, aromatic), 7.06 (1 H, d, J = 2.2, 
aromatic), 5.44 (1 H, t, J3,4 = J3,2 = 9.7, 3-H), 5.31 (1 H, t, J4-5 = 9.7, 4-H), 
4.40 (1 H, dd, J6,6‘  = 12.4, J5,6 = 4.4, 6-H), 4.13 (1 H, d, J1,2 = 8.7, 1-H), 4.06 
(1 H, dd, J5,6‘ = 1.9, 6‘-H), 3.40 (1 H, m, 5-H), 3.07 (1 H, t, 2-H), 1.81 (3 H, 
s, OAc), 1.78 (3 H, s, OAc), 1.63 (9 H, s, t-Bu), 1.51 (3 H, s, OAc), 1.32 (9 
H, s, t-Bu). 
13
C NMR(C6D6): δC = 166.4(2C), 166.1, 165.6, 165.3, 157.2, 
134.3, 127.2, 127.0, 114.9, 85.2, 70.5, 69.6, 68.8, 64.4, 57.9, 31.3, 25.8(3C), 
16.4, 16.3, 16.0. 3b: 
1
H NMR(C6D6): δH = 13.28 (1 H, s, OH), 7.90 (1 H, s, 
N=CH), 7.30 (1 H, d, J = 7.7, aromatic), 6.85 (1 H, d, J = 7.7, aromatic), 6.72 
(1 H, t, J = 7.7, aromatic), 5.34 (1 H, t, J3,4 = J3,2 = 9.7, 3-H), 5.24 (1 H, t, J4-5 
= 9.7, 4-H), 4.34 (1 H, dd, J6,6‘  = 12.4, J5,6 = 4.5, 6-H), 4.06 (1 H, d, J1,2 = 8.7, 
1-H), 4.00 (1 H, dd, J5,6‘ = 2.0, 6‘-H), 3.33 (1 H, m, 5-H), 2.91 (1 H, t, 2-H), 
1.74 (3 H, s, OAc), 1.69 (3 H, s, OAc), 1.52 (9 H, s, t-Bu), 1.45(3 H, s, 
OAc). 
13
C NMR(C6D6): δC = 166.9(2C), 166.1, 165.6, 165.3, 155.2, 133.8, 
124.7, 123.2, 114.3, 85.3, 70.6, 69.7, 69.0, 64.5, 58.0, 31.6, 30.4, 27.8(3C), 
25.8(3C), 16.3, 16.1(2C). 
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4.5.4 Preparation of elpaN-salen-dH2 and elpaN-salen-eH2: 
 
A solution of 3a/3b (1.0 mmol) in dry dichloromethane (5.0 mL) under inert 
atmosphere was added to a solution of P(Me)Ph2 (0.20 g, 1.0 mmol) in 
dichloromethane (5.0 mL) at 0°C. The system was stirred 2 h at RT, and then 
the desired aldehyde was added (1.0 mmol). After 20 h, the solvent was 
removed under vacuum and the crude product was purified by flash 
cromatography on silica gel (eluent: EtOAc / PE =1/3, NEt3 1%) elpaN-
salen-dH2: MS(MALDI) calcd. for C38H53N2O9 [LH]
+
: 681.38, found 
681.65. 
1
H NMR(C6D6): δH = 13.40 (1 H, s, OH),  13.32 (1 H, s, OH), 8.28 
(1 H, s, N=CH) 7.97 (1 H, s, N=CH), 7.55 (1 H, d, J = 2.2, aromatic), 7.22 (1 
H, d, J = 7.7, aromatic), 7.04 (1 H, d, J = 2.2, aromatic), 6.81 (1 H, d, , J = 
7.7, aromatic), 6.62 (1 H, t, J = 7.7, aromatic), 5.66 (1 H, t, J3,4 = J3,2 = 9.7, 3-
H), 5.38 (1 H, t, J4-5 = 9.7, 4-H), 4.45 (1 H, dd, J6,6‘  = 12.4, J5,6 = 4.6, 6-H), 
4.37 (1 H, d, J1,2 = 7.9, 1-H), 4.17 (1 H, dd, J5,6‘ = 1.8, 6‘-H), 3.52 (1 H, m, 5-
H), 3.08 (1 H, t, 2-H), 1.76 (6 H, s, OAc x 2), 1.58 (9 H, s, t-Bu), 1.54 (3 H, 
s, OAc), 1.44 (9 H, s, t-Bu), 1.29 (9 H, s, t-Bu). 
13
C NMR(C6D6): δC = 
167.1(2C), 166.2, 165.7, 165.6, 162.2(2C), 157.0, 155.0, 136.8, 133.9, 133.6, 
127.2, 127.0, 123.1, 114.8, 114.3, 87.8, 70.7, 70.5, 70.2, 64.9, 58.4, 31.6, 
31.2, 30.4, 27.8(3C), 25.9(3C), 25.8(3C), 16.5, 16.4, 16.2. IR: νmax/cm
−1
 = 
1751 (C=O), 1617 (C=N); MS(ESI) m/z = 681.65 (LH
+
) elpaN-salen-eH2: 
MS(MALDI) calcd. for C38H53N2O9 [MH]
+
: 681.38, found 681.53. 
1
H 
NMR(C6D6): δH = 13.47 (1 H, s, OH),  13.29 (1 H, s, OH), 8.29 (1 H, s, 
N=CH) 7.90 (1 H, s, N=CH), 7.53 (1 H, d, J = 1.9, aromatic), 7.25 (1 H, d, J 
= 7.4, aromatic), 6.97 (1 H, d, J = 2.1, aromatic), 6.87 (1 H, d, , J = 6.7, 
aromatic), 6.68 (1 H, t, J = 7.7, aromatic), 5.62 (1 H, t, J3,4 = J3,2 = 9.7, 3-H), 
5.39 (1 H, t, J4-5 = 9.7, 4-H), 4.48 (1 H, dd, J6,6‘  = 12.4, J5,6 = 4.5, 6-H), 4.40 
(1 H, d, J1,2 = 8.5, 1-H), 4.16 (1 H, dd, J5,6‘ = 1.5, 6‘-H), 3.53 (1 H, m, 5-H), 
3.03 (1 H, t, 2-H), 1.76 (3 H, s, OAc), 1.75 (3 H, s, OAc), 1.52 (3 H, s, 
OAc), 1.51 (9 H, s, t-Bu), 1.44 (9 H, s, t-Bu), 1.21 (9 H, s, t-Bu). 
13
C 
NMR(C6D6): δC = 170.6(2C), 170.2, 169.7, 169.5, 166.8, 161.0, 158.9, 
140.8, 138.0, 137.5, 131.0(2C), 127.4, 118.8, 118.7, 118.1, 92.4, 74.7, 74.3, 
74.1, 68.7, 62.3, 35.5, 35.2, 34.3, 31.6(3C), 29.7(3C), 29.7(3C), 20.5, 20.4, 
20.1. IR: νmax/cm
−1
 = 1751 (C=O), 1617 (C=N).  
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4.5.5. Preparation of elpaN-salen-c’H2: 
 
elpaN-salen-cH2 (0.50 mmol) was dissolved in methanol (15 mL), and a 
catalytic amount (5% respect to the ligand) of KOH was added. The reaction 
was controlled by TLC, and after 2h was complete. The solvent was 
removed under vacum, and the residue was dissolved in THF and  filtrated 
over a short pad of celite in order to remove the residual base. Evaporation 
of the solvent afforded the product in quantitative yield. 
1
H NMR(C6D6): δH 
= 13.77 (1 H, s, OH),  13.51 (1 H, s, OH), 8.36 (1 H, s, N=CH) 8.18 (1 H, s, 
N=CH), 7.54 (1 H, s, aromatic), 7.50 (1 H, s, aromatic), 7.07 (1 H, s, 
aromatic), 7.02 (1 H, s, aromatic), 4.58 (1 H, d, J1,2 = 8.5, 1-H), 3.99-3.90 (2 
H, m, 6-H + 6‘-H), 3.84 (1 H, t, J3,4 = J3,2 = 8.9, 3-H), 3.74 (1 H, t, J4,5 = J3,4, 
4-H), 3.47 (1 H, m, 5-H), 3.17 (1 H, t, 2-H), 1.64 (9 H, s, t-Bu), 1.50 (9 H, s, 
t-Bu), 1.26 (9 H, s, t-Bu), 1.22 (9 H, s, t-Bu). 
13
C NMR(C6D6): δC = 166.8, 
158.9, 140.7(2C), 137.4, 137.1, 127.4, 127.3, 118.6, 118.2, 93.4, 78.1, 76.5, 
75.9, 70.7, 62.7, 35.5(2C), 34.4(2C), 31.7(3C), 31.6(3C), 29.9(3C), 
29.8(3C). 
 
 
4.5.6. Preparation of [Mn(elpaN-salen)]PF6 complexes: 
 
The proper ligand (0.30 mmol) and Mn(OAc)2•4H2O (0.30 mmol) were 
dissolved in absolute ethanol (7 mL). The mixture was stirred bubbling air 
through the solution. After 8 h, a solution of NaPF6 (3.0 mmol) in 1.5 mL of 
water was added. After stirring further 18 h, water (50 mL) was added, 
obtaining a brown precipitate which was filtered and washed with water. The 
solid was dissolved in DCM, anhydrified with sodium sulphate, concentred 
and precipitated in hexane, obtaing the title products in 75-80% yield. 
[Mn(elpaN-salen-a)]PF6: found: C, 49.05; H, 5.22; N, 3.27; Mn, 6.69%. 
Calc. for C34H42F6MnN2O9P: C, 49.64; H, 5.15; N, 3.41; Mn, 6.68%; IR: 
νmax/cm
−1
 = 1751 (C=O), 1617 (C=N), 845 (PF6
−
); MS(ESI): 676.77 [M]
+
, 
144.91 [PF6]
−
. [Mn(elpaN-salen-b)]PF6: found: C, 50.79; H, 5.14; N, 3.56; 
Mn, 6.73%. Calc. for C34H42F6MnN2O9P: C, 49.64; H, 5.15; N, 3.41; Mn, 
6.68%; IR: νmax/cm
−1
 = 1752 (C=O), 1617 (C=N), 845 (PF6
−
); MS(ESI): 
677.14 [M]
+
, 144.91 [PF6]
−
. [Mn(elpaN-salen-c)]PF6: found: C, 53.39; H, 
6.45; N, 2.94; Mn, 5.64%. Calc. for C42H58F6MnN2O9P: C, 53.96; H, 6.25; 
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N, 3.00; Mn, 5.88%; IR: νmax/cm
−1
 = 1752 (C=O), 1610 (C=N), 843 (PF6
−
); 
MS(ESI): 789.35 [M]
+
, 144.91 [PF6]
−
. [Mn(elpaN-salen-d)]PF6: Found: C, 
52.12; H, 5.90; N, 3.27; Mn, 6.48%. Calc. for C38H50F6MnN2O9P: C, 51.94; 
H, 5.74; N, 3.19; Mn, 6.25%; IR: νmax/cm
−1
 = 1752 (C=O), 1613 (C=N), 843 
(PF6
−
); MS(ESI): 732.90 [M]
+
, 144.91 [PF6]
−
. [Mn(elpaN-salen-e)]PF6: 
found: C, 51.46; H, 5.88; N, 3.07; Mn, 5.99%. Calc. for C38H50F6MnN2O9P: 
C, 51.94; H, 5.74; N, 3.19; Mn, 6.25%; IR: νmax/cm
−1
 = 1752 (C=O), 1613 
(C=N), 843 (PF6
−
); MS(ESI): 732.90 [M]
+
, 144.91 [PF6]
-
.  
 
 
4.5.7. Preparation of complex [Mn(OH)(elpaN-salen-c’)]:  
 
Ligand elpaN-salen-c’H2 (0.30 mmol) and Mn(OAc)2•4H2O (0.30 mmol) 
were dissolved in absolute ethanol (7 mL), and the mixture was stirred for 8 
h bubbling air through the solution. After 18h, 50 mL of water were added, 
and the solution was extracted three times with dichloromethane. The 
organic phase was anhydrified with sodium sulphate, concentred and 
precipitated in hexane, obtaing the title product in 74% yield. Found: C, 
63.22; H, 7.70; N, 4.27; Mn, 8.28%. Calc. for C36H53MnN2O7: C, 63.52; H, 
7.85; N, 4.12; Mn, 8.07%; IR: νmax/cm
−1
 = 1618 (C=N); MS(MALDI): 
663.20 [M – OH]+.  
 
 
4.5.8. Typical procedure for the asymmetric epoxidation using m-
chloroperbenzoic acid as oxidant: 
 
The olefin substrate (0.48 mmol) and N-methylmorpholine-N-oxide (2.4 
mmol) were added to a solution of the appropriate Mn complex (0.024 mmol 
in 4 mL of dichloromethane. The mixture was cooled at 196 K, then m-
chloroperbenzoic acid (0.96 mmol) was added as a solid over a 2 min period. 
After an established period of time, 5 mL of 1 M NaOH were added, and the 
organic phase separated, washed with brine (10 mL) and dried over sodium 
sulphate. The resulting solution was purified by filtration through a small 
pad of silica gel. The solvent was removed under vacuum, and the yield was 
determined by 
1
H NMR using Eu(hfc)3 for the valutation of the ee%. 
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4.5.9. Typical procedure for the asymmetric epoxidation using NaClO 
as oxidant: 
 
cis--methylstyrene (0.48 mmol) and pyridine-N-oxide (0.072 mmol) 
were added to a solution of [Mn(elpaN-salen-b)]PF6 (0.024 mmol) in 
dichloromethane (1 mL). After the addition of 2 mL of buffered 
NaClO solution (1.0 mmol, pH 11.3) as the oxidant at 273 K, the 
resulting mixture was stirred vigorously. After 4.5h, the mixture was  
diluted with DCM (2.5 mL). The organic layer was separated, washed 
with brine, and then dried with sodium sulphate. The resulting 
solution was purified by filtration through a small pad of silica gel. 
The solvent was removed and yield was determined by 
1
H NMR using 
Eu(hfc)3 for the valutation of the ee%. 
 
 
4.5.10. Typical procedure for the asymmetric epoxidation using n-
Bu4HSO5 as oxidant.  
 
 cis--methylstyrene (0.48 mmol) and N-methylmorpholine-N-oxide (0.48 
mmol) were added to a solution of [Mn(elpaN-salen-b)]PF6 (0.024 mmol) in 
3 mL of acetonitrile. The mixture was cooled at -18°C, then the oxidant 
(0.75 mmol) was added as a solid over a 15 min period. After an established 
period of time, the reaction was quenched by adding dimethyl sulfide (ca. 1 
mmol). Excess solid K2CO3 was added, the mixture was allowed to reach 
room temperature and then filtered. The filtrate was concentrated and the 
residue was purified through a small pad of silica gel (eluent n-
hexane/ethylacetate = 9/1). The solvent was removed and yield was 
determined by 
1
H NMR using Eu(hfc)3 for the valutation of the ee%. 
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4.5.11. X-ray crystallography of elpaN-salen-bH2 
3: 
 
Single crystal suitable for X-ray analysis were obtained by slow evaporation 
of a methanol solution at ambient temperature. The quality of the crystals 
was rather poor as witnessed by the fact that the diffraction pattern gave few 
high θ reflections. Data were collected on a Bruker-Nonius Kappa-CCD 
diffractometer using graphite monochromated MoKα radiation (λ = 0.71073 
Å) at  ambient temperature. Unit cell parameters were determined by least 
squares refinement  of the θ angles of 70 strong reflections in the range 
3.089°<θ<12.966°. Data reduction and semiempirical absorption correction 
were done using SADABS program [27]. The structure was solved by direct 
methods (SIR97 program [28]) and refined by the full matrix least-squares 
method on F2 using SHELXL-97 program [30] with the aid of the program 
WinGX [31]. Non-hydrogen atoms were refined anisotropically; H atoms of 
hydroxyl groups were found in difference Fourier maps, the positions of the 
other H atoms were determined stereochemically. H atoms were refined by 
the riding model with Uiso = 1.2∙Ueq of the carrier atom (1.5∙Ueq for H 
atoms of methyl groups).  
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5. Pd (0) complexes with sugar-derived ligands for 
aqueous Suzuki-Miyaura cross-coupling. 
 
 
5.1 Background of the Pd-promoted  Suzuki-Miyaura cross-coupling: 
scope of the reaction, mechanisms, state of the art. 
Cross-coupling, defined as a catalytic reaction where two hydrocarbon 
fragments are coupled by a transition metal, is one of the most 
straightforward and general methods for the formation of C-C bonds. Several 
reactions can be defined as cross-coupling (Sonogashira, Negishi, Stille, 
etc…), and all share the same steps in the catalytic cycle: oxidative addition, 
trans-metallation and reductive elimination. Nevertheless, their  
developments has been surprisingly sluggish until a few decades ago.  
Before 1960 the scope of cross-coupling  was largely limited to those 
involving Mg and Li organoreagents.  Focusing on the Suzuki-Miyaura  
(SM) cross-coupling, only in 1978 Negishi and coworkers discovered that 2-
iodotoluene could be coupled with lithium 1-heptynyltributylborate, 
establishing for the first time that organoboranes were effective 
transmetalating agents in Pd-mediated cross-couplings [1]. Neutral 
alkenylboranes were next tested by Suzuki and Miyaura in 1979, [2] and in 
further works they found that the addition of a base was necessary to effect 
the cross-coupling of these organometallic species [3]. From then on, the 
methodology has evolved and has expanded its scope, and today the SM 
reaction is the most commonly applied cross-coupling reaction  in both 
academia and industry [4]. Several features can address the success of this 
methodology [5], which allowed Suzuki to be awarded of the Nobel prize in 
2010:  
 
1. ready availability of reactants. 
2. mild reaction conditions and high product yields. 
3. water stability. 
4. easy use of the reaction both in aqueous and heterogeneous conditions. 
5. toleration of a broad range of functional groups. 
6. high regio- and stereoselectivity of the reaction. 
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7. insignificant effect of steric hindrance. 
8. use of a small amount of catalysts. 
9. application in one-pot synthesis. 
10. nontoxic reaction. 
11. easy separation of inorganic boron compound. 
12. environmentally friendly process. 
 
The generic SM cross-coupling and the scope of reaction are reported below 
(Scheme 5.1): 
 
 
Scheme 5.1 
 
In this reaction a new C-C bond  is formed from an organic halide or pseudo-
halide and an organo-boron compound. Both sp
2
 and sp
3
 carbon may be 
involved in this process. A stoichiometric excess of base is necessary, 
whosechoice is dependent on the specific system.  
Typical solvents are ethereal and aromatic hydrocarbons, but in recent years 
the interests towards aqueous solvents increased [6], due to greener 
protocols. Aqueous conditions are the main topic of this chapter, hence the 
following discussion will focus on this field. 
As mentioned in the introduction, a diverse set of approaches can be used to 
make a process green and sustainable but, in general, reaction solvents have 
a key influence on the environmental impact and also affect cost, safety, and 
health issues. Organic solvents are volatile and highly inflammable, and 
often are at the origin of pollution. Thus, their substitution with alternative 
solvents presenting superior ecological, health, and safety properties is one 
way to make a protocol green and sustainable [7]. Examples are supercritical  
fluids, biosolvents, and ionic liquids, but often their costs are still 
challenging. Another alternative are solvent-free protocols,  which are 
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usually hardly applicable to industrial scales due to inadequate heat- and  
mass-transfer.  
On this basis, naturally abundant water is one of the best choices as a 
reaction medium because it is nontoxic, noncorrosive, nonflammable and has 
a low vapour pressure. The main drawback usually is low the solubility of 
substrates and catalysts in this medium, and this represent the main 
challenge for the research of  aqueous green protocols.  
Several systems, both homogenous and heterogeneous, demonstrated to be 
effective in aqueous Pd-promoted SM cross-coupling [6]. Notable examples 
are water-soluble phosphines and bipyridines, carbenes,  palladacycles, silica 
supported catalysts or alternative protocols involving the use of microwaves 
or surfactants.  
These systems have been used in a wide range of case-studies, and they 
represent the state of the art in terms of catalytic performances and 
applicability of the aqueous Pd-promoted SM cross-coupling. One excellent 
example is the synthesis of Diflunisal, a non-steroidal anti-inflammatory 
drug [7] (Scheme 5.2), which is obtained by aqueous-phase methodology in 
high yield in one step without use of organic solvents in the reaction or 
purification. 
  
 
Scheme 5.2 
 
 
5.1.1 Mechanism  
 
As any other  cross-coupling, the mechanism of the SM reaction has been 
extensively studied [8] and consists of three steps: oxidative addition, 
transmetalation and reductive elimination.   
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Scheme 5.3 
 
The oxidative addition is the rate limiting step of the cycle, and its rate 
depends on the halide (X) of the substrate,  increasing in the order X= Cl < 
Br < I. 
The transmetalation  is the reaction stage where the organic group R
2
 bound 
to the electropositive boron  is transferred to the catalyst. This is supposed to 
happen trough two different paths (A and B), but in both cases it is  
rationalized the observed enhancement in rate caused by the base. In Path A, 
the boronic acid react with the base  to form a borate which is sufficiently 
electron-rich to transmetalate with the Pd(II) species.  In Path B, a transient 
hydroxyl-palladium(II) adduct is formed prior to transmetalation with a 
neutral organoborane. In most SM cross-couplings, both Path A and B are 
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believed to be operational concurrently, and it is not immediately clear why 
one pathway predominates under a particular set of reaction conditions.   
In order to close the catalytic cycle, the reductive elimination step after the 
transmetalation process is needed. This step consists of the coupling of the 
two organic groups, R
1
 and R
2
, in cis position; if these are in trans position, 
an isomerization occours.  
 
 
5.1.2 State of the art: sugar derived ligands for aqueous SM cross-
coupling 
 
Although sugar-derived ligands have been applied in several catalytic C-C 
and C-X bond formation (X = O, N, S, P) [9], their scope has not been 
extended comprehensively to other powerful couplings, such as the Suzuki-
Miyaura reaction, where only some sporadic examples are reported [6, 10]. 
Nevertheless, in this field sugars candidate are really attractive building 
blocks, due to their solubility in water, which allow green and sustainable 
synthesis of biaryls. Moreover, their intrinsic chirality may promote the 
enantioselective synthesis of binaphthyl rings. 
Example of sugar-derived ligands for aqueous SM are reported in figure 5.1  
 
 
Figure 5.1 
 
In all the protocols reported the Pd complexes were formed in situ. The best 
performance was obtained with ligand L3, which afforded the coupling 
product of  4-bromoanisole and p-tolyl boronic acid with 62% yield at 25°C 
and 0.1% mol catalyst loading. 
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5.2 PN and NN  ligands and the corresponding Pd0 complexes: 
synthesis and characterization. 
 
In order to extend the use of sugar-derived ligands in aqueous SM, part of 
this PhD thesis focused on the development of new systems. The preparation 
of diphenylphosphino,imino (PN) and pyridino,imino (NN) sugar based 
ligands is reported, along with the synthesis of the corresponding hydrophilic 
Pd
0
 complexes (Figure 5.2, fdn= fumarodinitrile).  Some imino ligands, 
employed in Suzuki-Miyaura couplings, were reported in recent literature 
[11] but in all cases the activities ranged from  low to moderate.  
 
 
 
Figure 5.2 
 
The design of both PN and NN ligands was aimed at achieving higher TONs 
and ensuring their easy, high-yield synthesis. 
Four imino sugar residues were employed: three of them derive from glucose 
functionalized in positions 1, 2 and 6, respectively. The fourth is instead a 
mannoside derivatized  in 6. 
As expected, all the complexes were found to be soluble in aqueous media, 
and could be fruitfully employed in the aqueous SM coupling. 
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The strategy for the synthesis of the complexes involved three major steps. 
First, protected PN and NN ligands were synthesized from suitable 
precursors. In a second phase, the corresponding Pd(0) complexes 
[Pd(PN)(fdn)] or [Pd(NN)(fdn)] were prepared (step i in Scheme 5.3), which 
were in turn transformed into the deprotected hydrophilic species 
[Pd(PN*)(fdn)] or [Pd(NN*)(fdn)] (step ii). 
 
 
 
Scheme 5.3 
 
Some of the ligands were already known (Scheme 5.4) [12] ,  while the 
others were synthesized for the first time. The molecules were prepared from 
the corresponding amino or azido precursors 1, 2 and 3, by condensation 
with the proper aldehyde in the former case, and by aza-Wittig reaction in 
the latter cases. The products were isolated in high yield by column 
chromatography or precipitation. 
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Scheme 5.4 
 
The corresponding [Pd(PN)(fdn)] and [Pd(NN)(fdn)] complexes were 
prepared in good yield from fresh [Pd2(dba)3·CHCl3] (dba = 
dibenzylideneacetone) with an established procedure [12d], path i of 
Scheme 5.3.  
Dba molecules were readily displaced in toluene by one alkene and one 
chelating molecule, as revealed by the rapid change of colour of the reacting 
mixture from brown to orange-yellow. After removal of the solvent under 
vacuum, the complexes were obtained as yellow to orange microcrystalline 
solids by column chromatography over silica. All the isolated complexes 
could be handled in air at room temperature and were stored for several 
weeks at 277 K without appreciable decomposition.  
The compounds were characterized by proton, carbon and phosphorous 
NMR spectroscopy. Upon coordination to Pd, the signals of the olefin 
undergo a large shift at lower frequencies. This behaviour is reported in 
literature [12a, 12d, 13, 14], and is attributed to the substantial degree of π-
backdonation in the Pd(0)-olefin bond, which stabilizes the low oxidation 
state of palladium. The consequent partial re-hybridisation sp
2→sp3 of the 
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alkene carbons shift the corresponding signals towards the aliphatic regions 
in both 
1
H and 
13
C NMR spectra. 
It is worth to note that Pd
0
 compounds soluble in water are quite rare [12c, 
12d, 15]. The hydrophilic Pd
0
 complexes [Pd(PN*)(fdn)] and 
[Pd(NN*)(fdn)] were obtained by basic hydrolysis of the acetyl and benzoyl 
groups (path ii of Scheme 5.3). The yellow microcrystalline products, which 
are fairly soluble in water, methanol and ethanol, were isolated in high yield 
by precipitation with diethyl ether from the reaction mixture. Also in this 
case, all the isolated complexes could be handled in air at room temperature 
and were stored for several weeks at 277 K without appreciable 
decomposition. The only exception is complex [Pd(PN-G1*)(fdn)], which in 
solution slowly underwent a transformation to another species; this 
phenomenon is currently under study. 
In both the O-acylated and the deprotected species, the coordination of fdn 
affords two diastereoisomers, because the olefin is prochiral. The 
diastereoisomers are known to interconvert via an associative mechanism 
[14-16], where an external olefin coordinates to the metal with the 
enantioface opposite to that initially coordinated, which then dissociates.  
The isomeric equilibrium is rapidly reached after dissolution of the 
complexes, and the presence of two resolved patterns for the two isomers 
indicates that this process is slow at RT compared with the NMR time-scale 
(Figure 5.3 shows an example) [12a].
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Figure 5.3 
 
Integration of suitable separated peaks allowed to calculate the 
diastereomeric ratios, reported in Table 5.1. 
In almost all cases, a significant discrimination has been found. As a 
general consideration, the O-acylated complexes have a similar 
selectivity, with small differences for the two coordinating system (PN 
and NN; entry 1 vs 5, 2 vs 6; exceptions are entry  3 vs 7 , 4 vs 8), their 
position on the sugar backbone (C1, C2 and C6; entry 1 vs 2 vs 3 and 
entry 5 vs 6 vs 7, entry 7 beeing the only exception) and the epimer 
used (glucose and mannose; entry 3 vs 4 and 7 vs 8). 
The differences are larger among the deprotected complexes, where 
there is a general drop of selectivity, probably due to the lack of steric 
hindrance provided by the acyl groups. For these complexes, the 
presence of the bulky diphenylphosphino group provides a better 
selectivity compared with the pyridyl group (entry 12 vs 16).  
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a From ref. 12a. b from ref. 12c. 
Table 5.1 
 
5.3 Catalytic performances of the [Pd(PN*)fdn] and [Pd(NN*)fdn] 
complexes in aqueous SM cross-coupling. 
 
The Suzuki-Miyaura cross-coupling is an extremely useful tool for C-C bond 
formation, due to its versatility and efficiency [17].  
This reaction is usually performed in organic solvents, neat or mixed with 
water. The drawbacks of aqueous solvents are the low solubility of several 
substrates and the general lower stability of the metal catalysts in water. On 
this basis, in recent years a large variety of water-compatible protocols has 
been developed, which include hydrophilic complexes,
12,13
  surfactants,
14
  
and use of microwaves.
15
  However, only few of them display significant 
activity. 
A good compromise between organic and aqueous solvents is the use of 
ethanol/water mixtures, being small alcohols among the greenest solvents in 
terms of impact on health and environment, and in term of the energy needed 
for manufacture and disposal.
16
 Ethanol increases the solubility of the 
substrate, does not interfere with the separation of the product (as surfactants 
Entry Complex Solvent 
Diastereomeric  
ratio 
1
a
 [Pd(PN-G1)(fdn)] CDCl3 70:30 
2 [Pd(PN-G2)(fdn)] CDCl3 86:14 
3
a
 [Pd(PN-G6)(fdn)] CDCl3 72:28 
4
a
 [Pd(PN-M6)(fdn)] CDCl3 80:20 
5
b
 [Pd(NN-G1)(fdn)] CDCl3 80:20 
6 [Pd(NN-G2)(fdn)] CDCl3 84:16 
7 [Pd(NN-G6)(fdn)] CDCl3 55:45 
8 [Pd(NN-M6)(fdn)] CDCl3 60:40 
9 [Pd(PN-G1*)(fdn)] CD3OD 50:50 
10 [Pd(PN-G2*)(fdn)] CD3OD 60:40 
11 [Pd(PN-G6*)(fdn)] CD3OD 87:13 
12 [Pd(PN-M6*)(fdn)] CD3OD  73:27  
13
b
 [Pd(NN-G1*)(fdn)] CD3OD 55:45 
14 [Pd(NN-G2*)(fdn)] CD3OD 65:35 
15 [Pd(NN-G6*)(fdn)] CD3OD 50:50 
16 [Pd(NN-M6*)(fdn)] CD3OD 50:50 
116 
 
do) and is bio-available at a low cost. Hydro-alcoholic mixtures are the 
media of choice
17
 for reducing the use of dangerous, environmental-
unfriendly organic solvents, and aiming to an easy separation of the product 
from the reacting system. 
For these reasons, the water soluble complexes [Pd(PN*)(fdn)] and 
[Pd(NN*)(fdn)] were tested in the Suzuki-Miyaura reaction in ethanol/water 
mixtures.  It is worth to note that a protocol should be intended as ―truly 
green‖ when  toxic organic solvent are not involved in any step, including 
the workup
 
[10]. Our workup procedure involved an extraction with DCM 
and a chromatography using Hex/EtOAc mixtures, but this choice was due 
to the small scale of our screening reactions and the  necessity of reporting 
isolated yield also for partial conversion. In test experiments, we 
demonstrated that, with higher scales and complete conversion, it was 
possible to isolate the pure hydrophobic products in almost quantitative 
yields by simple addition of water followed by filtration of the solid 
products. Analogue protocols were already reported in literature[23].      
In principle also the parent O-acylated [Pd(PN)(fdn)] and [Pd(NN)(fdn)] 
species may function as pre-catalysts, because in the basic coupling 
conditions the acyl groups are expected to hydrolyze easily. Nevertheless, 
the deprotected species were preliminarily isolated in order to demonstrate 
their actual existence, and, hence, for assessing the nature of the catalytic 
complexes. 
Furthermore, their high solubility in ethanol allowed to prepare concentrated 
stock solutions for an accurate dosage of the catalyst. 
The first screenings were performed in order to optimize the reaction 
conditions (Table 5.2) in terms of ethanol/water ratio (entries 1-5), 
concentration (entries 3, 6, 7), and equivalents of base (entries 8-12). 
Phenylboronic acid and 4-bromoanisole were used as benchmark substrates, 
while [Pd(PN-M6*)(fdn)] was selected as catalyst. 
The reaction in neat ethanol or water (respectively entries 1 and 5) resulted 
in poor yield. This was expected,  because the former is not able to dissolve 
the base, while the latter does not dissolve the substrate properly. The best 
water/ethanol ratio resulted to be 1/1 (entry 3).  
This ratio was used in order to adjust the concentration, using a total volume 
of 6, 4 and 3 mL (entries 3, 6 and 7). Unexpectedly, the highest 
concentration resulted in a drop of activity, probably because the resulting 
higher concentration of complex favours the formation of metallic Pd. 
117 
 
Similar behaviours are reported in literature for the formation of  Pd2Te3 
nanoparticles [24]. 
 
Conditions: 4-bromoanisole (0.50 mmol), phenylboronic acid (0.55 mmol), catalyst [Pd(PN-
M6*)(fdn)], 5*10-3mmol, 1mol%), 1h, 120°C. aAverage of two runs. 
Table 5.2 
 
The volume resulting in the best yield (4 mL, entry 6) was used for the 
screening of the equivalents of base. As reported, its presence is fundamental 
for this reaction, as confirmed by entry 8. The highest yield was obtained 
with 2 equivalents of base with respect to the aryl bromide (entry 10). 
The optimized conditions were used in the next screening, where lower 
amounts of catalyst were used (Table 5.3). 
 
Entry Catalyst loading (mol %)
a 
Isolated yield (%)
b 
TOF (h
-1
) 
1 1.0 80 80 
2 0.10 95 950 
3 0.010 75 7500 
4 0.0050 83 16600 
5 0.0010 0 0 
Conditions: 4-bromoanisole (0.5 mmol), phenylboronic acid (0.55 mmol), catalyst: [Pd(PN-
M6*)(fdn)], K2CO3 (1.0 mmol), water (2 mL), ethanol (2 mL), 1h, 120°C. 
aCatalyst loading 
with respect to 4-bromoanisole. bAverage of two runs. 
Table 5.3 
 
Entry 
EtOH/H2O  
(v/v) 
Volume 
(mL) 
K2CO3 
(mmol) 
Isolated 
yield
a
(%) 
1 6/0 6 1.5  5 
2 2/1 6 1.5  32 
3 1/1 6 1.5  47 
4 1/2 6 1.5  42 
5 0/6 6 1.5  12 
6 1/1 4 1.5  69 
7 1/1 3 1.5  57 
8 1/1 4 without base 0 
9 1/1 4 0.50 21 
10 1/1 4 1.0 80 
11 1/1 4 2.25  61 
12 1/1 4 3.0  56 
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Interestingly, catalyst loading less than 1.0 mol% resulted in higher yield, 
most likely due to the mentioned faster deactivation of the catalyst with 
formation metallic Pd at higher complex concentration. The catalyst resulted 
in no activity decreasing to 0.0010 mol% (entry 5). 
On these bases, other complexes were tested with a loading of 0.010 mol% 
or lower, in order to find the most active catalyst (Table 5.4). 
All the PN complexes and one NN complex were tested at a catalyst loading 
of 0.010% with good results (entries 1-4). The best performing PN species 
and the NN complex, namely [Pd(PN-G1*)(fdn)] and  [Pd(NN-M6*)(fdn)] 
were then examined at the lower ratios, respectively 0.0050% and 0.0020% 
(entries 5-8). In the latter case, the PN catalysts showed lack of 
reproducibility, with isolated yields ranging from 0 to 15%.  
 
Entry 
 
Complex 
Catalyst loading 
(mol %)
a
 
Isolated 
yield
b
(%) 
1 [Pd(PN-G1*)(fdn)] 0.010 87 
2 [Pd(PN-G2*)(fdn)] 0.010 56 
3 [Pd(PN-G6*)(fdn)] 0.010 72 
4 [Pd(NN-M6*)(fdn)] 0.010 68 
5 [Pd(PN-G1*)(fdn)] 0.0050 58 
6 [Pd(NN-M6*)(fdn)] 0.0050 97 
7 [Pd(PN-G1*)(fdn)] 0.0020 0-15 
8 [Pd(NN-M6*)(fdn)] 0.0020 65 
Conditions: 4-bromoanisole (0.5 mmol), phenylboronic acid (0.55 mmol), K2CO3 (1.0 mmol), 
water (2 mL), ethanol (2 mL), 1h, 120°C. aCatalyst loading with respect to 4-bromoanisole. 
bAverage of two runs. 
Table 5.4 
 
Given the satisfying result achieved with [Pd(NN-M6*)(fdn)], the whole NN 
family was tested in the same condition with good yield, demonstrating that 
they are more active than the corresponding PN species (Table 5.5).  
Only [Pd(NN-G1*)(fdn)] revealed to be almost ineffective, probably due to 
the higher sensitivity of the sugar functionalized in position C1. 
The complexes [Pd(NN-G2*)(fdn)] and [Pd(NN-G6*)(fdn)] were further 
employed at 0.0010% loading, where they presented still appreciable yield 
after 1h, while [Pd(NN-M6*)(fdn)] was ineffective and hence not reported in 
table (entries 4-5).  
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Conditions: 4-bromoanisole (0.5 mmol), phenylboronic acid (0.55 mmol), K2CO3 (1.0 mmol), 
water (2 mL), ethanol (2 mL), 1h, 120°C. aCatalyst loading with respect to 4-bromoanisole. 
bAverage of two runs. cReaction time: 4h. 
Table 5.5 
 
When the reaction was prolonged up to 4h, the yield increased to 38% (entry 
6-7), demonstrating that the complexes are still active after the first hour of 
reaction. The activities of the two complexes were almost the same. 
On the ground of the easier synthesis, the entire set of substrates was tested 
by selecting [Pd(NN-G2*)(fdn)] as the catalyst of choice (Table 5.6). 
The catalyst resulted effective also over sterical demanding substrates, (entry  
2, 3, 8, 9) although with slightly lower activity, and towards substrates with 
electron releasing or electron withdrawing groups.  
 
 
Entry R1 R2 Isolated Yield
a
(%) 
1 4-OMe 4-Me 74 
2 4-OMe 3-Me 63 
3 4-OMe 2-Me 48 
4 4-OMe 4-NO2 <5 
5 4-OMe 4-CHO 25 
6 4-OMe 4-OH <5 
7 4-OMe 4-OMe 33 
8 2-OMe H 30 
9 3-OMe H 76 
10 4-NO2 H 85 
11 4-OH H 15 
12 4-CHO H 85 
13 H H 50 
Conditions: aryl bromide (0.50 mmol), arylboronic acid (0.55 mmol), catalyst [Pd(NN-
G2*)(fdn)], 5*10-5mmol, 0.010 mol%), 1h, 120°C. aAverage of two runs. 
Table 5.6 
Entry Complex 
Catalyst loading 
(mol %)
a
 
Isolated 
yield
b
(%) 
1 [Pd(NN-G6*)(fdn)] 0.0020 65 
2 [Pd(NN-G1*)(fdn)] 0.0020 4 
3 [Pd(NN-G2*)(fdn)] 0.0020 70 
4 [Pd(NN-G6*)(fdn)] 0.0010 12 
5 [Pd(NN-G2*)(fdn)] 0.0010 12 
6
c 
[Pd(NN-G6*)(fdn)] 0.0010 37 
7
c 
[Pd(NN-G2*)(fdn)] 0.0010 38 
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5.4 Conclusion. 
 
In this work, two classes of Pd
0
 water-soluble complexes (PN and NN) were 
prepared and tested in the Suzuki-Miyaura cross-coupling, using aqueous 
environmental-friendly conditions.  The best catalyst, namely  [Pd(NN-
G2*)(fdn)], was active at really low loading (0.0010%) and resulted to be 
tolerant towards different substrates and very efficient by comparison with 
reported systems; the TOFs are up to 9.5·10
3 
h
-1
, which is close to the best 
results [25] for reactions in aqueous medim. 
 
 
5.5 Experimentals. 
 
5.5.1. General consideration: 
 
NMR spectra were recorded in CDCl3 (CHCl3, δ = 7.26 and 
13
CDCl3 δ 77, as 
internal standards), C6D6 (TMS, δ = 0 and 
13
C6D6 δ 128.6, as internal 
standards) and CD3OD (CHD2OD, δ = 3.34 and 
13
CD3OD δ 49.9 as internal 
standards) with a 200 MHz (Varian Model Gemini), and a 400 MHz (Bruker 
DRX-400) spectrometers. 
31
P NMR experiments were carried out using 
aqueous 85% phosphoric acid as external reference (δ 0). The following 
abbreviations were used for describing NMR multiplicities: s, singlet; d, 
doublet; dd, double doublet; t, triplet; dt, double triplet; m, multiplet; app, 
apparent, br broad. PN-G1, PN-G2, PN-G6, PN-M6, NN-G1, [Pd(PN-
G1)(fdn)], [Pd(PN-G6)(fdn)], [Pd(PN-M6)(fdn)], [Pd(NN-G1)(fdn)], 
[Pd(NN-G1*)(fdn)] were prepared according to literature methods [12a,b,c]. 
THF was distilled from LiAlH4, dichloromethane from CaH2.  
 
 
5.5.2. Preparation of NN-G2: 
  
The amino intermediate 1 (640 mg, 2.0 mmol) was suspended in 25 mL of 
EtOH (abs), then 2-pyridincarboxyaldehyde (240 mg, 2.20 mmol)  was 
added. After 72h, hexane (80 mL) was added, and the precipitated product 
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was filtrated and washed 3 times with hexane (yield: 560 mg, 69%) 
obtaining a white powder. Detailed presentation of physical data for NN-G2: 
[Found: C, 55.64; H, 5.85; N, 7.01. C19H24N2O8 requires C, 55.88; H, 5.92; 
N, 6.86]; δH (400 MHz; C6D6; TMS ) 8.64 (1 H, d, 
3
J = 4.6 Hz, aromatic), 
8.31 (1 H, s, N=CH), 7.97 (1 H, d, 
3
J = 7.8 Hz, aromatic), 7.73 (1 H, t,  
3
J = 
7.7 Hz, aromatic), 7.33 (1 H, dd, 
3
J = 5.4 Hz, 
3
J = 6.7 Hz, aromatic), 5.43 (1 
H, t, 
3
J3,4 = 
3
J3,2  = 9.6 Hz, 3-H), 5.14 (1H, t, 
3
J3,4 = 
3
J4,5, 4-H), 4.69 (1 H, d, 
3
J1,2 = 7.8 Hz, 1-H), 4.36 (1 H,  dd, 
3
J6,5 = 4.6 Hz, 
gem
J6,6‘ = 12.2 Hz, 6-H), 
4.18 (1 H, dd, 
3
J6‘,5 = 1.8 Hz, 6‘-H), 3.84 (1 H, m, 5-H), 3.49 (3 H, s, OMe), 
3.42 (1 H, t, 2-H), 2.10 (3 H, s, OAc), 2.03 (3 H, s, OAc), 1.88 (3 H, s, 
OAc). δC (100 MHz, C6D6, TMS) 171.2, 170.3, 170.2, 166.2, 154.3, 149.9, 
137.1, 125.6, 122.2, 102.9, 74.4, 73.5, 72.3, 69.0, 62.6, 57.6, 21.2, 21.1, 
21.0. 
 
4.5.3 Preparation of NN-G6 and NN-M6: 
 
Adapting a known procedure [12d], the desired azide (810 mg, 2.0 mmol) 
was dissolved in 10 mL of dry dichloromethane under argon. Then, 2-
pyridincarboxyaldehyde (235 mg, 2.2 mmol, 210 μL) and PPh2Me (440 mg, 
410 μL, 2.2 mmol) were added in this order at 0°C. the reaction was left to 
heat up to RT, and after 72h the solvent was removed under vacuum. The 
crude product was purified by column chromatography on florisil (eluent 
Hex/EtOAc=1/1), (yields: NN-G6 480 mg, 51%; NN-M6 510 mg, 54%). 
Detailed presentation of physical data for NN-G6: [Found: C, 61.49; H, 
5.68; N, 5.83. C24H26N2O8 requires C, 61.27; H, 5.57; N, 5.95]; δH (400 
MHz; C6D6; TMS) 8.48 (1 H, s, N=CH), 8.44 (1 H, d, 
3
J = 4.8 Hz, aromatic), 
8.13 (2 H, m, aromatic), 8.06 (1 H, d, 
3
J = 7.9 Hz, aromatic), 7.16-6.97 (4 H, 
m, aromatic), 6.60 (1 H, m, aromatic), 6.19 (1 H, t, 
3
J3,4 = 
3
J3,2 = 9.9 Hz, 3-H), 
5.73 (1 H, t, 
3
J3,4 = 
3
J4,5, 4-H), 5.14 (1 H, dd, 
3
J1,2 = 3.7 Hz, 2-H), 4.91 (1 H, d, 
1-H), 4.38 (1 H, m, 5-H), 3.78 (1 H, dd, 
3
J6,5 = 3.1 Hz, 
gem
J6,6‘ = 13.0 Hz, 6-
H), 3.58 (1 H, dd, 
3
J6‘,5 = 6.7 Hz, 6‘-H), 3.01 (3 H, s, OMe), 1.60 (3 H, s, 
OAc), 1.58 (3 H, s, OAc). δC (100 MHz, C6D6, TMS) 169.8, 165.7, 165.0, 
155.6, 149.7, 136.1, 133.4, 130.4 (2X), 130.2, 128.8(2X), 124.6, 97.1, 72.0, 
71.9, 70.8, 69.0, 61.5, 54.9, 32.1, 23.1, 20.3, 14.5. NN-M6: [Found: C, 
61.10; H, 5.54; N, 6.03. C24H26N2O8 requires C, 61.27; H, 5.57; N, 5.95]; δH 
(400 MHz; C6D6; TMS) 8.46 (1 H, s, N=CH), 8.42 (1 H, d, 
3
J = 4.2 Hz, 
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aromatic), 8.07 (3 H, m, aromatic), 7.16-6.97 (4 H, m, aromatic), 6.60 (1 H, 
m, aromatic), 6.09 (1 H, t, 
3
J3,4 = 
3
J4,5 =  9.6 Hz, 4-H), 6.02 (1 H, dd, 
3
J3,2 = 
3.3 Hz, 3-H), 5.63 (1 H, dd, 
3
J1,2 = 1.7 Hz, 2-H), 4.54 (1 H, d, 1-H), 4.45 (1 
H, m, 5-H), 3.90 (1 H, dd, 
3
J6,5 = 1.4 Hz, 
gem
J6,6‘ = 11.3 Hz, 6-H), 3.70 (1 H, 
dd, 
3
J6‘,5 = 7.3 Hz, 6‘-H), 2.98 (3 H, s, OMe), 1.67 (3 H, s, OAc), 1.56 (3 H, 
s, OAc). δC (100 MHz, C6D6, TMS) 169.8, 165.8, 164.8, 155.6, 149.6, 136.0, 
133.4, 130.3 (2X), 130.2, 128.9, 128.8, 128.7, 124.6, 120.9, 98.9, 70.6, 70.4, 
70.0, 69.4, 62.0, 54.8, 20.4, 20.3. 
 
 
5.5.4 General procedure for the preparation of the [Pd(ligand)(fdn)] 
complex: 
 
Adapting a known procedure [12d], [Pd2(dba)3•CHCl3] (215 mg, 0.21 mmol) 
was added to a solution of the desired ligand (0.50 mmol) and fdn (39 mg, 
0.50 mmol) in toluene (5 mL). After 1h, the solution was filtered over celite 
and the solvent was evaporated; the crude product was purified by column 
chromatography over silica (eluent Hex/EtOAc = 1/1 for PN family, neat 
EtOAc for NN family), isolating the pure product as a yellow 
microcrystalline solid (yield 68-85%). Detailed presentation of physical data 
for: [Pd(PN-G2)(fdn)] [Found: C, 55.87; H, 4.56; N, 5.55. C36H36N3O8PPd 
requires C, 55.71; H, 4.68; N, 5.41]; major diastereoisomer δH (400 MHz; 
CDCl3; CHCl3) 8.29 (1 H, d, 
4
JH,P = 1.5 Hz, N=CH), 7.65-7.05 (14 H, m, 
aromatics), 6.08 (1 H, t, 
3
J3,4 = 
3
J3,2 = 9.6 Hz, 3-H), 5.12 (1 H, t, 
3
J3,4 = 
3
J4,5, 4-
H), 5.04 (1 H, d, 
3
J1,2 = 7.8 Hz, 1-H), 4.36 (1 H, dd, 
3
J6,5 = 4.0 Hz, 
gem
J6,6 = 
12.3 Hz, 6-H), 4.24 (1 H, m, 5-H), 4.14 (1 H, dd, 
3
J6‘,5 = 1.8 Hz, 6‘-H), 3.44 
(1 H, t, 2-H), 3.20 (3 H, s, OMe), 3.14 (1 H, dd, 
3
JH,H = 9.6 Hz, 
cis
JH,P = 3.0 
Hz, fdn), 2.99 (1 H, t, 
3
JH,H = 
trans
JH,P , fdn), 2.07 (3 H, s, OAc), 2.04 (3 H, s, 
OAc), 1.67 (3 H, s, OAc). δC (100 MHz; CDCl3; 
13
CDCl3) 170.7, 170.2, 
170.1, 169.1, 137.7, 137.6, 137.3, 137.1, 135.2, 134.1, 133.9, 133.8, 132.9, 
132.7, 132.7, 132.6, 131.7, 131.4, 130.8, 130.6, 129.5, 129.4, 129.2, 129.1, 
101.1, 80.9, 73.8, 72.2, 69.3, 62.0, 57.2, 27.1, 25.4 (JC,P = 44 Hz), 20.5, 20.5, 
20.0. δP (162 MHz; CDCl3; H3PO4) 16.15. Relevant signal for the minor 
diastereoisomer: δH (400 MHz; CDCl3; CHCl3) 8.36 (1 H, d, 
4
JH-P = 1.5 Hz 
N=CH), 5.78 (1 H, t, 
3
J3,4 = 
3
J3,2 = 9.6 Hz, 3-H), 5.19 (1 H, d, 
3
J1,2 = 7.8 Hz, 1-
H), 3.39 (3 H, s, OMe), 2.61 (1 H, t, 
3
JH,H = 
trans
JH,P = 9.6 Hz, fdn). Detailed 
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presentation of physical data for: [Pd(NN-G2)(fdn)] [Found: C, 46.73; H, 
4.52; N, 9.30. C23H26N4O8Pd requires C, 46.59; H, 4.42; N, 9.45] major 
diastereoisomer δH (400 MHz; CDCl3; CHCl3) 8.92 (1 H, d, 
3
J = 4.6 Hz, 
aromatic), 8.43 (1 H, s, N=CH), 8.05 (1 H, d, 
3
J = 7.3 Hz, aromatic), 7.76 (1 
H, t,  
3
J = 7.6 Hz, aromatic), 7.67 (1 H, dd, 
3
J = 5.5 Hz, 
3
J = 6.8 Hz, 
aromatic), 5.82 (1 H, t, 
3
J3,4 = 
3
J3,2 = 9.6 Hz, 3-H), 5.17 (1 H, t, 
3
J3,4 = 
3
J4,5, 4-
H), 4.93 (1 H, d, 
3
J1,2 = 7.6 Hz, 1-H), 4.41 (1 H, dd, 
3
J6,5 = 4.1 Hz, 
gem
J6,6‘ 
=12.4 Hz, 6-H), 4.16 (1 H, dd, 
3
J6‘,5 = 1.2 Hz, 6‘-H), 4.08 (1 H, m, 5-H), 3.71 
(1 H, t, 2-H), 3.51 (3 H, s, OMe), 3.24 (1 H, d, 
3
JH,H= 9.5 Hz, fdn), 2.99 (1 H, 
d, fdn), 2.09 (3 H, s, OAc), 2.06 (3 H, s, OAc), 1.93 (3 H, s, OAc). δC (100 
MHz; CDCl3; 
13
CDCl3) 171.1, 170.6, 169.6, 166.9, 153.7, 152.4, 139.4, 
129.7, 127.6, 124.3, 122.9, 101.4, 74.9, 74.8, 72.1, 68.8, 62.2, 58.1, 21.2, 
21.1, 21.1, 20.1, 19.8. relevant signal for the minor diastereoisomer: δH (400 
MHz; CDCl3; CHCl3) 8.37 (1 H, s, N=CH), 5.60 (1 H, t, 
3
J3,4 = 
3
J3,2 =  9.6 Hz, 
3-H), 5.19 (1 H, t, 
3
J3,4 = 
3
J4,5, 4-H), 4.98 (1 H, d, 
3
J1,2 = 7.6 Hz, 1-H), 3.58 (3 
H, s, OMe), 3.00 (1 H, d, 
3
JH,H = 9.5 Hz, fdn), 2.91 (1 H, d, fdn). Detailed 
presentation of physical data for: [Pd(NN-G6)(fdn)]: [Found: C, 51.65; H, 
4.44; N, 8.86. C28H28N4O8Pd requires C, 51.35; H, 4.31; N, 8.55]; relevant 
signals for the major diastereoisomer δH (400 MHz; CDCl3; CHCl3) 8.84 (1 
H, d, 
3
J = 4.5 Hz, aromatic), 8.40 (1 H, s, N=CH), 8.08 (1 H, d, 
3
J = 7.3 Hz, 
aromatic), 5.79 (1 H, t, 
3
J3,4 = 
3
J3,2 = 9.6 Hz, 3-H), 5.27 (1 H, t, 
3
J3,4 = 
3
J4,5, 4-
H), 4.94 (2 H, m, 1-H + 2-H), 4.81 (1 H, m, 5-H), 3.55 (3 H, s, OMe), 2.97 
(1 H, d, 
3
JH,H = 9.2 Hz, fdn), 2.91 (1 H, s, fdn), 2.09 (3 H, s, OAc), 1.92 (3 H, 
s, OAc). relevant signals for the minor diastereoisomer: δH (400 MHz; 
CDCl3; CHCl3)  8.58 (1 H, d, 
3
J = 4.5 Hz, aromatic), 8.28 (1 H, s, N=CH), 
3.53 (3 H, s, OMe). the other signals are in the following regions: δH (400 
MHz; CDCl3; CHCl3) 8.06 – 7.02 (15 H, aromatics), 4.21 - 4.00 (m), 3.83 
(m). δC (100 MHz; CDCl3; 
13
CDCl3) 170.9, 170.9, 170.1, 169.9, 166.4, 
166.1, 165.2, 164.9, 153.7, 153.4, 152.6, 152.4, 143.8, 139.4, 139.0, 135.1, 
134.3, 134.1, 131.0, 130.6, 130.4, 129.4, 129.2, 129.1, 128.8 (2X), 128.6, 
128.4, 127.0, 126.8, 125.8, 123.2, 123.0, 122.7, 97.2, 97.0, 72.3, 71.5 (2X), 
71.1, 70.2, 70.0, 69.1, 68.2, 65.3, 63.7, 57.1, 56.4, 21.2 (2X), 21.0 (2X), 
19.3, 18.9, 18.8, 18.7. Detailed presentation of physical data for: [Pd(NN-
M6)(fdn)]: [Found: C, 51.61; H, 4.14; N, 8.77. C28H28N4O8Pd requires C, 
51.35; H, 4.31; N, 8.55]; major diastereoisomer δH (400 MHz; C6D6; TMS) 
8.46 (2 H, d, 
3
J = 7.3 Hz, aromatic), 8.05 (1 H, d, 
3
J = 4.7 Hz, N=CH), 7.26-
6.86 (4 H, m, aromatics), 6.70 (1 H, t, 
3
J = 7.6 Hz, aromatic), 6.30 (2 H, m, 
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aromatic), 6.06 (1 H, dd, 
3
J3,4 = 10.1 Hz,  
3
J3,2 = 3.3 Hz, 3-H), 5.94 (1 H, t, 
3
J3,4 = 
3
J4,5 , 4-H), 5.68 (1 H, dd, 
3
J1,2 = 1.6 Hz,  
3
J3,2 = 3.3 Hz, 2-H), 4.97 (1 H, 
m, 5-H), 4.39 (1 H, m, 1-H), 3.95 (1 H, d, 
3
J6,6‘ = 12.4 Hz, 6-H), 3.40 (1 H, 
dd, 
3
J5,6‘ = 9.6 Hz, 6‘-H), 3.33 (3 H, s, OMe), 2.82 (2 H, s, Hz, fdn), 1.73 (3 
H, s, OAc), 1.59 (3 H, s, OAc). relevant signal for the minor 
diastereoisomer: δH (400 MHz; C6D6; TMS) 8.13 (2 H, d, 
3
J = 7.3 Hz, 
aromatic), 7.92 (d, 1H, 
3
J = 4.0 Hz, N=CH), 7.26 - 6.86 (4 H, m, aromatics), 
6.64 (1 H, t, 
3
J = 7.0 Hz, aromatic), 6.34 (2 H, m, aromatic), 6.10 (1 H, dd, 
3
J3,4 = 10.0 Hz,  
3
J3,2 = 3.3 Hz, 3-H), 5.88 (1 H, t, 
3
J3,4 = 
3
J4,5, 4-H), 5.72 (1 H, 
dd, 
3
J1,2 = 1.5 Hz,  
3
J3,2 = 3.0 Hz, 2-H), 4.94 (1 H, m, 5-H), 4.55 (1 H, m, 1-
H), 3.90 (1 H, d, 
gem
J6,6‘ = 12.1 Hz, 6-H), 3.82 (1 H, dd, 
3
J5,6‘ = 9.6 Hz, 6‘-H), 
3.35 (3 H, s, OMe), 2.82 (2 H, s, fdn), 1.73 (3 H, s, OAc), 1.53 (3 H, s, 
OAc). δc (100 MHz; C6D6; TMS) for the two distereoisomer: 169.7, 169.6, 
169.5, 169.4, 166.7, 166.3, 164.1 (2X), 163.9, 153.0 (2X), 152.6, 152.2, 
152.1, 137.8 (2X), 137.5, 135.5, 134.2, 133.8, 130.9, 130.4, 129.4, 129.3, 
129.2, 129.0, 128.7, 125.6, 122.9, 122.7 (2X), 122.6 (2X), 104.0, 99.3, 99.0, 
70.8, 70.3, 70.2, 70.0, 69.9, 69.8, 69.6, 68.5, 65.6, 63.4, 56.5, 55.7, 20.5 
(2X), 20.3 (2X), 20.2, 20.1, 19.3, 19.2.  
 
 
5.5.5. General procedure for the preparation of the [Pd(ligand*)(fdn)] 
complexs: 
 
The desired [Pd(ligand)(fdn)] complex (0.50 mmol) was suspended in 5 mL 
of methanol, and KOH was added (2.8 mg, 0.050 mmol). The reaction was 
monitored by NMR, taking a small sample of the solution, evaporating the 
solvent and dissolving the residue in CD3OD. After completion, the solution 
was concentrated to 0.5 mL and the product was precipitated adding 10 mL 
of diethyl ether. The yellow, microcrystalline product was washed 3 times 
with diethyl ether and dried under vacuum (yield: 80-95%). Detailed 
presentation of physical data for: [Pd(PN-G1*)(fdn)]: [Found: C, 54.39; H, 
4.28; N, 6.32. C29H28N3O5PPd requires C, 54.77; H, 4.44; N, 6.61]; relevant 
signals for the major diastereoisomer δH (400 MHz; CD3OD; CHD2OD) 8.69 
(1 H, d, 
4
JH,P = 2.5 Hz N=CH), 7.80-7.10 (28 H, m, aromatics), 4.55 (1 H, d, 
3
J1,2 = 8.3 Hz, 1-H), 2.81 (1 H, t, 2-H), δP (162 MHz; CD3OD; H3PO4) 22.9; 
relevant signals for the minor diastereoisomer: δH (400 MHz; CD3OD; 
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CHD2OD)  8.61 (1 H, d, 
4
JH,P = 2.8 Hz, N=CH), 4.43 (1 H, d, 
3
J1,2 = 8.3 Hz, 
1-H), δP (162 MHz; CD3OD; H3PO4) 21.9; the other signals are in the 
following regions: δH (400 MHz; CD3OD; CHD2OD) 3.98-3.90 (3 H, m), 
3.85-3.75 (2 H, m), 3.69-3.53 (4 H, m), 3.52-3.42 (4 H, m), 3.16-3.00 (2 H, 
m), δC (100 MHz; CD3OD; 
13
CD3OD) 172.79, 171.56, 164.0-130.0 
(aromatics), 128.7, 128.5, 126.4 (2X), 105.6, 104.4, 83.5, 83.0, 81.9, 81.8, 
76.8, 76.7, 74.8, 73.9, 66.4, 65.7, 27.3 (d, JP,C = 44 Hz), 26.9 (2X, d, JP,C = 59 
Hz), 26.4 (d, JP,C = 46 Hz). Detailed presentation of physical data for 
[Pd(PN-G2*)(fdn)]: [Found: C, 55.81; H, 4.50; N, 6.29. C30H30N3O5PPd 
requires C, 55.44; H, 4.65; N, 6.46]; relevant signals for the major 
diastereoisomer δH (400 MHz; CD3OD; CHD2OD) 8.46 (1 H, d, 
4
JH,P = 2.9 
Hz, N=CH), 5.12 (1 H, d, 
3
J1,2 = 7.9 Hz, 1-H), 4.36 (1 H, t, 
3
J3,4 = 
3
J3,2 = 9.2 
Hz, 3-H), 3.93 (1 H, dd, 
3
J6,6‘ = 11.4 Hz, 
3
J5,6 = 1.4 Hz, 6-H), 3.21 (3 H, s, 
OMe), 3.16 (1 H, d, JH,H = 8.0 Hz, fdn), 2.86 (1 H, t, JH,H = JH,P fdn), δP (162 
MHz; CD3OD; H3PO4) 18.9; relevant signals for the minor diastereoisomer: 
δH (400 MHz; CD3OD; CHD2OD)  8.45 (1 H, d, 
4
JH,P = 2.7 Hz N=CH), 5.04 
(1 H, d, 
3
J1,2 = 7.9, 1-H), 4.22 (1 H, t, 
3
J3,4 = 
3
J3,2 = 9.2 Hz, 3-H), 3.89 (1 H, 
dd, 
gem
J6,6‘ = 11.4, 
3
J5,6 = 1.4 Hz, 6-H), 3.10 (3 H, s, OMe), 3.09 (1 H, dd, JH,H 
= 8.0 JH,P = 3.5Hz, fdn), 2.84 (1 H, t, JH,H = JH,P = 8.0 Hz, fdn) δP (162 MHz; 
CD3OD; H3PO4) 18.5; the other signals are in the following regions: δH (400 
MHz; CD3OD; CHD2OD) 7.75 (2 H, m, aromatics), 7.66 (2 H, m, 
aromatics), 7.60-7.30 (22 H, m, aromatics), 7.08 (2 H, m), 3.78-3.66 (3 H, 
m), 3.55-3.45 (3 H, m), δC (100 MHz; CD3OD; 
13
CD3OD)  170.5, 170.0, 
137.8 – 129.0 (aromatics),  122.2, 103.9, 101.4, 82.2, 81.0, 76.8, 76.4, 73.5, 
72.9, 70.8, 70.5, 61.6, 61.4, 56.6, 56.2, 23.6,  22.5, 22.3 (d, JP,C = 46 Hz), 
21.8 (d, JP,C = 46 Hz). Detailed presentation of physical data for [Pd(PN-
G6*)(fdn)]: [Found: C, 55.11; H, 4.88; N, 6.62. C30H30N3O5PPd requires C, 
55.44; H, 4.65; N, 6.46]; relevant signals for the major diastereoisomer δH 
(400 MHz; CD3OD; CHD2OD) 8.51 (1 H, d, 
4
JH,P = 2.0 Hz, N=CH), 8.01 (1 
H, d, 
3
J = 7.8 Hz, aromatics), 7.84 (1 H, m, aromatics), 7.72 (1 H, t, 
3
J= 7.6 
Hz, aromatics), 7.59 (1 H, t, 
3
J= 7.4 Hz, aromatics), 7.50-7.15 (10 H, m, 
aromatics), 4.77 (1 H, d, 
gem
J6,6‘ = 11.4 Hz, 6-H), 4.35 (1 H, d, 
3
J1,2 = 3.6, 1-
H), 4.12 (1 H, t, 
3
J5,6 =  
3
J5,4 = 9.3Hz, 5-H), 3.90 (1 H, t, 6‘-H), 3.62 (1 H, t, 
3
J3,4 = 
3
J3,2 =  9.1 Hz, 3-H), 3.30 (dd, covered by the signal of the solvent, 2-
H), 3.16 (2 H, m, 4-H + fdn), 2.94 (1 H, t, 
3
JH,H = 
trans
JH,P =  9.7 Hz, fdn), 2.50 
(3 H, s, OMe); δC (100 MHz; CD3OD; 
13
CD3OD)   171.4, 140.9, 140.5, 
138.5, 136.2, 136.1, 135.6, 135.5, 135.3, 134.3, 133.3, 132.9, 131.8, 131.5, 
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131.4, 131.0, 125.0, 102.0, 89.4, 76.4, 75.0, 74.9, 73.5, 59.7, 56.2, 32.1, 
26.5, 25.7, 25.3, 19.7; δP (162 MHz; CD3OD; H3PO4) 20.2. relevant signals 
for the minor diastereoisomer: δH (400 MHz; CD3OD; CHD2OD) 8.42 (1 H, 
d, 
4
JH,P = 2.0 Hz, N=CH), 4.57 (1 H, d, 
gem
J6,6‘ = 10.6 Hz, 6-H), 4.47 (1 H, d, 
3
J1,2 = 4.5 Hz, 1-H); δP (162 MHz; CD3OD; H3PO4) 19.7. Detailed 
presentation of physical data for: [Pd(PN-M6*)(fdn)]: [Found: C, 55.76; H, 
4.87; N, 6.48. C30H30N3O5PPd requires C, 55.44; H, 4.65; N, 6.46]; relevant 
signals for the major diastereoisomer δH (400 MHz; CDCl3; CHCl3)  8.37 (1 
H, bs, N=CH major ), 4.79 (1 H, d, 
3
J6,6‘ = 11.0 Hz, 6-H), 4.47 (1 H, s, 1-H), 
3.68 (1 H, t, 
3
J3,4 = 
3
J5,4 = 9.5 Hz, 3-H), 3.20 (1 H, dd,
 3
JH,H = 9.6 Hz,  
cis
JH,P = 
2.9 Hz, fdn), 2.89 (1 H, t, 
3
JH,H = 
trans
JH,P, fdn), 2.61 (3 H, s, OMe); relevant 
signals for the minor diastereoisomer: δH (400 MHz; CDCl3; CHCl3) 8.37 (1 
H, bs, N=CH), 4.71 (1 H, d, 
3
J6,6‘= 11.3 Hz, 6-H), 4.48 (1 H, s, 1-H), 3.65 (1 
H, t, 
3
J3,4 = 
3
J5,4 = 9.5 Hz, 3-H),  3.11 (1 H, dd,
 3
JH,H = 9.6 Hz,  
cis
JH,P=3.0 Hz, 
fdn), 2.74 (1 H, t, 
3
JH,H = 
trans
JH,P, fdn), 2.53 (3 H, s, OMe); the other signals 
are in the following regions: δH (400 MHz; CDCl3; CHCl3) 7.65-7.10 (m, 
aromatics), 4.20-3.55 (m) δC (100 MHz; CDCl3; CHCl3) 169.3, 168.5, 137.9 
– 129.3 (aromatics), 125.1, 123.0, 100.8, 100.7, 73.2, 72.4, 72.2, 70.9 (2X), 
70.4, 70.0, 69.7, 54.4, 54.2, 25.2, 24.7, 23.8 ( JP-C = 43 Hz ), 22.6 ( JP-C = 44 
Hz ). δP (162 MHz; CD3OD; H3PO4) 17.8. Detailed presentation of physical 
data for: [Pd(NN-G2*)(fdn)]: [Found: C, 43.59; H, 4.35; N, 11.67. 
C17H20N4O5Pd requires C, 43.74; H, 4.32; N, 12.00]; relevant signals for the 
major diastereoisomer δH (400 MHz; CD3OD; CHD2OD) 8.63 (1 H, s, 
N=CH), 4.92 (1 H, d, 
3
J1,2 = 7.7 Hz, 1-H), 3.50 (3 H, s, OMe), 3.02 (2 H, 
ABq, fdn); relevant signals for the minor diastereoisomer: δH (400 MHz; 
CD3OD; CHD2OD) 8.60 (1 H, s, 1H, N=CH), 4.90 (1 H, d, 
3
J1,2 = 7.7 Hz, 1-
H), 3.57 (3 H, s, 3H, OMe), 2.97 (2 H, s, fdn); the other signals are in the 
following regions: δH (400 MHz; CD3OD; CHD2OD) 8.87 (m, aromatics), 
8.16 (m, aromatics), 7.95 (m, aromatics), 7.64 (m, aromatics), 4.11 (t, J = 8.7 
Hz), 3.97-3.85 (m), 3.60-3.32 (m), 3.07-2.94(m) δC (100 MHz; CD3OD; 
13
CD3OD)  171.32, 171.06, 157.2, 157.1 (2X), 157.0, 143.8 (2X), 133.1, 
131.5, 127.7, 126.8, 108.2, 106.1, 81.1, 80.7, 80.1, 79.6, 77.7, 74.7, 74.1, 
69.8, 65.6, 65.4, 60.5, 60.3, 21.2, 20.9, 18.4. Detailed presentation of 
physical data for [Pd(NN-G6*)(fdn)]: [Found: C, 44.01; H, 4.36; N, 11.66. 
C17H20N4O5Pd requires C, 43.74; H, 4.32; N, 12.00]; relevant signals for the 
major diastereoisomer δH (400 MHz; CD3OD; CHD2OD) 8.62 (1 H, s, 
N=CH), 4.59 (1 H, d, 
3
J1,2 = 2.0 Hz, 1-H), 4.27 (1 H, t, 
3
J3,4 = 
3
J4,5 = 9.0 Hz, 
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4-H), 3.76 (1 H, t, 
3
J6,5 = 
3
J6,6‘ = 10.0 Hz, 6-H), 3.42 (3 H, s, OMe), 2.94 (2 
H, ABq, fdn), relevant signals for the minor diastereoisomer: δH (400 MHz; 
CD3OD; CHD2OD) 8.59 (1 H, s,  N=CH), 4.57 (1 H, d, 
3
J1,2 = 2.0 Hz, 1-H), 
4.24 (1 H, t, 
3
J3,4 = 
3
J4,5 = 9.0 Hz, 4-H), 3.86 (1 H, t, 
3
J6,5 = 
3
J6,6‘ = 10.0 Hz, 6-
H), 3.30 (3 H, s, OMe), 2.91 (2 H, s, fdn); the other signals are in the 
following regions: δH (400 MHz; CD3OD; CHD2OD) 8.85 (2 H, m, 
aromatics), 8.15 (2 H, m, aromatics), 7.92 (2 H, m, aromatics), 7.62 (2 H, m, 
aromatics), 4.48 (2 H, m),   3.70-3.65 (2 H, m), 3.50-3.25 (2 H, m); δC (100 
MHz; CD3OD; 
13
CD3OD) 166.1, 165.7, 152.8 (2X), 152.5, 152.3, 139.0 
(2X), 128.1 (2X), 126.3 (2X), 122.4 (2X), 122.0 (2X), 99.4, 99.03, 73.4 
(2X), 72.0 (2X), 71.8 (2X), 70.3, 69.2, 64.0, 63.0, 54.5, 53.8, 16.5 (2X), 15.3 
(2X). Detailed presentation of physical data for [Pd(NN-M6*)(fdn)]: 
[Found: C, 43.39; H, 4.18; N, 12.36. C17H20N4O5Pd requires C, 43.74; H, 
4.32; N, 12.00]; relevant signals for the major diastereoisomer δH (400 MHz; 
CD3OD; CHD2OD) 8.63 (1 H, s, N=CH), 3.30 (3 H, s, OMe); relevant 
signals for the minor diastereoisomer: δH (400 MHz; CD3OD; CHD2OD) 
8.61 (1 H, s, N=CH), 3.29 (3 H, s, OMe); the other signals are in the 
following regions: δH (400 MHz; CD3OD; CHD2OD) 8.85 (m, aromatics), 
8.14 (m, aromatics), 7.92 (m, aromatics), 7.70 (m, aromatics), 4.50 (m), 4.20 
(m), 3.78 (m),  3.63 (m), 2.91 (m, fdn); δC (100 MHz; CD3OD; 
13
CD3OD) 
170.8, 170.4, 157.6 (2X) , 157.3 (2X), 143.8 (2X), 132.8 (2X), 131.0 (2X), 
127.1, 126.8, 105.7, 105.4, 75.9, 75.4 (2X), 75.1, 74.9 (2X), 73.3, 73.1, 68.8, 
67.7, 58.9, 58.2, 21.3 (2X) , 19.9 (2X). 
 
 
5.5.7. Typical procedure for the Suzuki-Miyaura coupling:  
 
To a solution of phenylboronic acid (0.55 mmol, 67 mg) and 4-bromanisole 
(0.50 mmol, 63 µL) in 1 mL of ethanol absolute were added a solution of 
potassium carbonate (1.00 mmol, 138 mg) in 2 mL of water and an 
opportune volume of a solution of the catalyst in ethanol absolute. The 
system was heated up to 120°C. After 1h the product was extract with 
dichloromethane (10 mL x 3 times), dried with anhydrous sodium sulfate, 
filtered and concentrated under vacuum. The solution was filtered through a 
short pad of silica and then chromatographed over Silica Gel (eluent: 
hexanehexane / ethyl acetate 4:1). The structure of the pure product was 
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confirmed by MS and by comparison of the NMR spectra with data reported 
in literature.  
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6. Conclusions. 
 
 
The main aim of this PhD thesis was the development of a new family of 
chiral ligands derived from D-glucose (elpaN-type). These ligands were 
designed in order to be pseudo-enantiomeric respect to the previously 
developed Naple-type family, and focusing on the obtainment of easy and 
straightforward synthesis.  
On this basis, three libraries of elapN-type ligands were prepared and 
successfully employed in homogenous metal-promoted asymmetric 
catalysis: the elpaN-phos, for the Pd-promoted Asymmetric Allylic 
Substitution; the elpaN-py, for the Mo-promoted   Asymmetric Allylic 
Alkylation enhanced by microwaves; the elpaN-Salen, for the Mn-promoted 
Asymmetric Epoxidation. 
In all cases, performances were excellent and inversion of selectivity respect 
to the Naple-type family was achieved. In the particular case of the elpaN-
phos subset, a phase-tagged version of the ligand was successfully employed 
in multiphase catalysis, achieving the recycle of the catalyst. 
The secondary aim of this PhD thesis was the development of a library of 
sugar-derived, water soluble Pd
0
 complexes for aqueous Suzuki-Miyaura 
cross-coupling. Also in this case, good performances were obtained (TOF up 
to 9500 h
-1
), among the best in literature for this reaction in aqueous, 
sustainable condition. 
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dopo li rileggo, constatando che in questo lasso di tempo è cambiato molto. 
Persone sono entrate ed uscite dalla mia vita, ed ho affrontato le numerose 
prove di chi si affaccia ai 30. Non mi dilungherò, ma guardandomi indietro 
vorrei solo dire: bravo il dottorando! 
Inoltre ringrazio in ordine sparso: i tre Giovanni che hanno avuto un ruolo 
molto importante nella mia vita (Giovanni Peroni, Giovanni il Lungo e 
Giovanni il Camminatore), Pino Mauro, Il Dio Nilo per avermi protetto, 
l‘amico Izzo, tutti i tesisti con cui ho lavorato in questi anni, Grazia e Franco 
del campetto degli aranci. 
 
 
 
 
 
